WO2003027249A2 - High-protein-phenotype-associated plant genes - Google Patents
High-protein-phenotype-associated plant genes Download PDFInfo
- Publication number
- WO2003027249A2 WO2003027249A2 PCT/US2002/030475 US0230475W WO03027249A2 WO 2003027249 A2 WO2003027249 A2 WO 2003027249A2 US 0230475 W US0230475 W US 0230475W WO 03027249 A2 WO03027249 A2 WO 03027249A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- nucleic acid
- ofthe
- acid molecule
- polypeptide
- Prior art date
Links
- 108700001094 Plant Genes Proteins 0.000 title description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 452
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 202
- 238000000034 method Methods 0.000 claims abstract description 112
- 241000196324 Embryophyta Species 0.000 claims description 391
- 230000014509 gene expression Effects 0.000 claims description 193
- 235000018102 proteins Nutrition 0.000 claims description 189
- 150000007523 nucleic acids Chemical class 0.000 claims description 170
- 102000039446 nucleic acids Human genes 0.000 claims description 137
- 108020004707 nucleic acids Proteins 0.000 claims description 137
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 127
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 114
- 229920001184 polypeptide Polymers 0.000 claims description 107
- 239000002773 nucleotide Substances 0.000 claims description 106
- 125000003729 nucleotide group Chemical group 0.000 claims description 106
- 108020004414 DNA Proteins 0.000 claims description 90
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 81
- 239000013598 vector Substances 0.000 claims description 78
- 230000001105 regulatory effect Effects 0.000 claims description 51
- 239000003550 marker Substances 0.000 claims description 41
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 33
- 239000000523 sample Substances 0.000 claims description 33
- 235000013339 cereals Nutrition 0.000 claims description 27
- 238000013518 transcription Methods 0.000 claims description 26
- 230000035897 transcription Effects 0.000 claims description 26
- 230000000692 anti-sense effect Effects 0.000 claims description 21
- 239000013612 plasmid Substances 0.000 claims description 20
- 241000209510 Liliopsida Species 0.000 claims description 19
- 241001233957 eudicotyledons Species 0.000 claims description 15
- 230000001965 increasing effect Effects 0.000 claims description 15
- 230000000295 complement effect Effects 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000003780 insertion Methods 0.000 claims description 9
- 230000037431 insertion Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 108700026244 Open Reading Frames Proteins 0.000 claims description 7
- 108091023040 Transcription factor Proteins 0.000 claims description 7
- 102000040945 Transcription factor Human genes 0.000 claims description 7
- 230000003828 downregulation Effects 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 230000003190 augmentative effect Effects 0.000 claims description 5
- 230000007246 mechanism Effects 0.000 claims description 5
- 230000001172 regenerating effect Effects 0.000 claims description 5
- 230000001124 posttranscriptional effect Effects 0.000 claims description 3
- 108010064851 Plant Proteins Proteins 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000021118 plant-derived protein Nutrition 0.000 claims description 2
- 230000009918 complex formation Effects 0.000 claims 4
- 244000144972 livestock Species 0.000 claims 2
- 238000003801 milling Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 164
- 240000008042 Zea mays Species 0.000 description 89
- 102000053602 DNA Human genes 0.000 description 86
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 86
- 210000001519 tissue Anatomy 0.000 description 75
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 64
- 235000009973 maize Nutrition 0.000 description 64
- 230000009466 transformation Effects 0.000 description 46
- 229920002477 rna polymer Polymers 0.000 description 44
- 238000009396 hybridization Methods 0.000 description 40
- 230000009261 transgenic effect Effects 0.000 description 40
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 39
- 240000007594 Oryza sativa Species 0.000 description 38
- 235000007164 Oryza sativa Nutrition 0.000 description 38
- 235000009566 rice Nutrition 0.000 description 36
- 235000001014 amino acid Nutrition 0.000 description 34
- 239000012634 fragment Substances 0.000 description 34
- 229940024606 amino acid Drugs 0.000 description 29
- 150000001413 amino acids Chemical class 0.000 description 29
- 238000003752 polymerase chain reaction Methods 0.000 description 28
- 108010055615 Zein Proteins 0.000 description 26
- 229920002494 Zein Polymers 0.000 description 25
- 239000000047 product Substances 0.000 description 24
- 238000006467 substitution reaction Methods 0.000 description 24
- 230000014616 translation Effects 0.000 description 24
- 244000105624 Arachis hypogaea Species 0.000 description 22
- 108091026890 Coding region Proteins 0.000 description 22
- 230000001939 inductive effect Effects 0.000 description 22
- 241000894007 species Species 0.000 description 22
- 238000013519 translation Methods 0.000 description 22
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 20
- 235000005822 corn Nutrition 0.000 description 20
- 108020004999 messenger RNA Proteins 0.000 description 20
- 241000219823 Medicago Species 0.000 description 19
- 239000002299 complementary DNA Substances 0.000 description 19
- 239000005019 zein Substances 0.000 description 19
- 229940093612 zein Drugs 0.000 description 19
- 235000010469 Glycine max Nutrition 0.000 description 18
- 244000068988 Glycine max Species 0.000 description 18
- 244000207740 Lemna minor Species 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 18
- 108020004705 Codon Proteins 0.000 description 17
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 241000589158 Agrobacterium Species 0.000 description 16
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 16
- 244000046052 Phaseolus vulgaris Species 0.000 description 16
- 108700019146 Transgenes Proteins 0.000 description 16
- 238000009395 breeding Methods 0.000 description 16
- 230000001488 breeding effect Effects 0.000 description 16
- 244000013123 dwarf bean Species 0.000 description 16
- 230000002103 transcriptional effect Effects 0.000 description 16
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 15
- 244000064895 Cucumis melo subsp melo Species 0.000 description 15
- 241000209499 Lemna Species 0.000 description 15
- 235000006439 Lemna minor Nutrition 0.000 description 15
- 240000006394 Sorghum bicolor Species 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 239000013615 primer Substances 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 14
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 14
- 241000208125 Nicotiana Species 0.000 description 14
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 14
- 241000209140 Triticum Species 0.000 description 14
- 235000021307 Triticum Nutrition 0.000 description 14
- 238000010367 cloning Methods 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 240000001980 Cucurbita pepo Species 0.000 description 13
- 241000219739 Lens Species 0.000 description 13
- 235000005489 dwarf bean Nutrition 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- 235000010582 Pisum sativum Nutrition 0.000 description 12
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 238000012217 deletion Methods 0.000 description 12
- 230000037430 deletion Effects 0.000 description 12
- 230000002068 genetic effect Effects 0.000 description 12
- 235000020232 peanut Nutrition 0.000 description 12
- 230000008117 seed development Effects 0.000 description 12
- 244000045232 Canavalia ensiformis Species 0.000 description 11
- 241000234295 Musa Species 0.000 description 11
- 241000219843 Pisum Species 0.000 description 11
- 244000061456 Solanum tuberosum Species 0.000 description 11
- 238000002105 Southern blotting Methods 0.000 description 11
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 230000002363 herbicidal effect Effects 0.000 description 11
- 239000004009 herbicide Substances 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 210000002706 plastid Anatomy 0.000 description 11
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 11
- 230000035882 stress Effects 0.000 description 11
- 230000008685 targeting Effects 0.000 description 11
- 235000007119 Ananas comosus Nutrition 0.000 description 10
- 235000011331 Brassica Nutrition 0.000 description 10
- 241000219198 Brassica Species 0.000 description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 10
- 244000020518 Carthamus tinctorius Species 0.000 description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
- 235000003222 Helianthus annuus Nutrition 0.000 description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 description 10
- 240000005979 Hordeum vulgare Species 0.000 description 10
- 241000219745 Lupinus Species 0.000 description 10
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 240000003768 Solanum lycopersicum Species 0.000 description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 description 10
- 241000219793 Trifolium Species 0.000 description 10
- 241000219977 Vigna Species 0.000 description 10
- 235000010726 Vigna sinensis Nutrition 0.000 description 10
- 238000007792 addition Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 244000283070 Abies balsamea Species 0.000 description 9
- 235000007173 Abies balsamea Nutrition 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 241000209524 Araceae Species 0.000 description 9
- 235000010777 Arachis hypogaea Nutrition 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
- 235000008577 Pinus radiata Nutrition 0.000 description 9
- 241000218621 Pinus radiata Species 0.000 description 9
- 235000001855 Portulaca oleracea Nutrition 0.000 description 9
- 101710166307 Protein lines Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229930182817 methionine Natural products 0.000 description 9
- 102000040430 polynucleotide Human genes 0.000 description 9
- 108091033319 polynucleotide Proteins 0.000 description 9
- 239000002157 polynucleotide Substances 0.000 description 9
- 239000002243 precursor Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 230000010076 replication Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 235000013311 vegetables Nutrition 0.000 description 9
- 240000007241 Agrostis stolonifera Species 0.000 description 8
- 241000335053 Beta vulgaris Species 0.000 description 8
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 8
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 8
- 235000009467 Carica papaya Nutrition 0.000 description 8
- 235000010523 Cicer arietinum Nutrition 0.000 description 8
- 244000045195 Cicer arietinum Species 0.000 description 8
- 240000006740 Cichorium endivia Species 0.000 description 8
- 240000008067 Cucumis sativus Species 0.000 description 8
- 235000009854 Cucurbita moschata Nutrition 0.000 description 8
- 235000009852 Cucurbita pepo Nutrition 0.000 description 8
- 241000219146 Gossypium Species 0.000 description 8
- 235000003228 Lactuca sativa Nutrition 0.000 description 8
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 8
- 235000014826 Mangifera indica Nutrition 0.000 description 8
- 244000025272 Persea americana Species 0.000 description 8
- 235000008673 Persea americana Nutrition 0.000 description 8
- 240000007377 Petunia x hybrida Species 0.000 description 8
- 235000007238 Secale cereale Nutrition 0.000 description 8
- 244000078534 Vaccinium myrtillus Species 0.000 description 8
- 235000010749 Vicia faba Nutrition 0.000 description 8
- 240000006677 Vicia faba Species 0.000 description 8
- 235000002098 Vicia faba var. major Nutrition 0.000 description 8
- 240000004922 Vigna radiata Species 0.000 description 8
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 8
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000003733 chicria Nutrition 0.000 description 8
- 230000001976 improved effect Effects 0.000 description 8
- 230000000977 initiatory effect Effects 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 8
- 230000001404 mediated effect Effects 0.000 description 8
- 230000002018 overexpression Effects 0.000 description 8
- 244000099147 Ananas comosus Species 0.000 description 7
- 235000007319 Avena orientalis Nutrition 0.000 description 7
- 244000075850 Avena orientalis Species 0.000 description 7
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 7
- 235000002566 Capsicum Nutrition 0.000 description 7
- 235000002767 Daucus carota Nutrition 0.000 description 7
- 244000000626 Daucus carota Species 0.000 description 7
- 108010044091 Globulins Proteins 0.000 description 7
- 102000006395 Globulins Human genes 0.000 description 7
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 7
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 7
- 241000208818 Helianthus Species 0.000 description 7
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 239000006002 Pepper Substances 0.000 description 7
- 235000016761 Piper aduncum Nutrition 0.000 description 7
- 240000003889 Piper guineense Species 0.000 description 7
- 235000017804 Piper guineense Nutrition 0.000 description 7
- 235000008184 Piper nigrum Nutrition 0.000 description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 244000061458 Solanum melongena Species 0.000 description 7
- 244000062793 Sorghum vulgare Species 0.000 description 7
- 235000021536 Sugar beet Nutrition 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- -1 e.g. Proteins 0.000 description 7
- 239000003623 enhancer Substances 0.000 description 7
- 230000030279 gene silencing Effects 0.000 description 7
- 238000001155 isoelectric focusing Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000019713 millet Nutrition 0.000 description 7
- 230000031787 nutrient reservoir activity Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N Abscisic acid Natural products OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 6
- 108700028369 Alleles Proteins 0.000 description 6
- 241000234282 Allium Species 0.000 description 6
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 6
- 244000144725 Amygdalus communis Species 0.000 description 6
- 235000011437 Amygdalus communis Nutrition 0.000 description 6
- 244000226021 Anacardium occidentale Species 0.000 description 6
- 240000002791 Brassica napus Species 0.000 description 6
- 241001674345 Callitropsis nootkatensis Species 0.000 description 6
- 241000207199 Citrus Species 0.000 description 6
- 241001672694 Citrus reticulata Species 0.000 description 6
- 235000013162 Cocos nucifera Nutrition 0.000 description 6
- 244000060011 Cocos nucifera Species 0.000 description 6
- 241000218631 Coniferophyta Species 0.000 description 6
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 6
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 6
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 6
- 240000006497 Dianthus caryophyllus Species 0.000 description 6
- 244000078127 Eleusine coracana Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 240000002395 Euphorbia pulcherrima Species 0.000 description 6
- 235000005206 Hibiscus Nutrition 0.000 description 6
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 6
- 244000267823 Hydrangea macrophylla Species 0.000 description 6
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 6
- 244000017020 Ipomoea batatas Species 0.000 description 6
- 235000002678 Ipomoea batatas Nutrition 0.000 description 6
- 244000183376 Lemna aequinoctialis Species 0.000 description 6
- 244000207747 Lemna gibba Species 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- 241000234479 Narcissus Species 0.000 description 6
- 240000007817 Olea europaea Species 0.000 description 6
- 101710089395 Oleosin Proteins 0.000 description 6
- 235000007199 Panicum miliaceum Nutrition 0.000 description 6
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 6
- 241000218606 Pinus contorta Species 0.000 description 6
- 235000013267 Pinus ponderosa Nutrition 0.000 description 6
- 240000004713 Pisum sativum Species 0.000 description 6
- 240000001416 Pseudotsuga menziesii Species 0.000 description 6
- 241000208422 Rhododendron Species 0.000 description 6
- 108010016634 Seed Storage Proteins Proteins 0.000 description 6
- 240000005498 Setaria italica Species 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- 235000009470 Theobroma cacao Nutrition 0.000 description 6
- 241000218638 Thuja plicata Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 244000022203 blackseeded proso millet Species 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000020971 citrus fruits Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 210000001938 protoplast Anatomy 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 241000724328 Alfalfa mosaic virus Species 0.000 description 5
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 5
- 240000006108 Allium ampeloprasum Species 0.000 description 5
- 240000002234 Allium sativum Species 0.000 description 5
- 241000219318 Amaranthus Species 0.000 description 5
- 235000004047 Amorpha fruticosa Nutrition 0.000 description 5
- 240000002066 Amorpha fruticosa Species 0.000 description 5
- 244000144730 Amygdalus persica Species 0.000 description 5
- 240000007087 Apium graveolens Species 0.000 description 5
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 5
- 235000010591 Appio Nutrition 0.000 description 5
- 241000218156 Aquilegia Species 0.000 description 5
- 235000003911 Arachis Nutrition 0.000 description 5
- 244000003416 Asparagus officinalis Species 0.000 description 5
- 235000005340 Asparagus officinalis Nutrition 0.000 description 5
- 235000000832 Ayote Nutrition 0.000 description 5
- 235000016068 Berberis vulgaris Nutrition 0.000 description 5
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 5
- 235000006008 Brassica napus var napus Nutrition 0.000 description 5
- 240000000385 Brassica napus var. napus Species 0.000 description 5
- 240000007124 Brassica oleracea Species 0.000 description 5
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 5
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 5
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 5
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 5
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 5
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 5
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 5
- 235000004936 Bromus mango Nutrition 0.000 description 5
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 5
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 5
- 241000219173 Carica Species 0.000 description 5
- 241000219312 Chenopodium Species 0.000 description 5
- 235000007516 Chrysanthemum Nutrition 0.000 description 5
- 244000298479 Cichorium intybus Species 0.000 description 5
- 241001633993 Cineraria Species 0.000 description 5
- 241000219109 Citrullus Species 0.000 description 5
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 5
- 241000522193 Coronilla Species 0.000 description 5
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 5
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 5
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 5
- 241000612153 Cyclamen Species 0.000 description 5
- 235000017788 Cydonia oblonga Nutrition 0.000 description 5
- 240000004585 Dactylis glomerata Species 0.000 description 5
- 235000012040 Dahlia pinnata Nutrition 0.000 description 5
- 244000033273 Dahlia variabilis Species 0.000 description 5
- 241000208296 Datura Species 0.000 description 5
- 241000202296 Delphinium Species 0.000 description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 5
- 240000008620 Fagopyrum esculentum Species 0.000 description 5
- 235000016623 Fragaria vesca Nutrition 0.000 description 5
- 240000009088 Fragaria x ananassa Species 0.000 description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 5
- 241000735332 Gerbera Species 0.000 description 5
- 241000245654 Gladiolus Species 0.000 description 5
- 240000005322 Gloxinia perennis Species 0.000 description 5
- 241000234473 Hippeastrum Species 0.000 description 5
- 241001495448 Impatiens <genus> Species 0.000 description 5
- 241000208822 Lactuca Species 0.000 description 5
- 235000011430 Malus pumila Nutrition 0.000 description 5
- 235000015103 Malus silvestris Nutrition 0.000 description 5
- 241001093152 Mangifera Species 0.000 description 5
- 240000003183 Manihot esculenta Species 0.000 description 5
- 241000213996 Melilotus Species 0.000 description 5
- 235000009072 Mesembryanthemum Nutrition 0.000 description 5
- 241000219480 Mesembryanthemum Species 0.000 description 5
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 5
- 240000002853 Nelumbo nucifera Species 0.000 description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 5
- 241000208181 Pelargonium Species 0.000 description 5
- 241000219833 Phaseolus Species 0.000 description 5
- 235000006089 Phaseolus angularis Nutrition 0.000 description 5
- 235000008566 Pinus taeda Nutrition 0.000 description 5
- 241000218679 Pinus taeda Species 0.000 description 5
- 235000000497 Primula Nutrition 0.000 description 5
- 241000245063 Primula Species 0.000 description 5
- 235000009827 Prunus armeniaca Nutrition 0.000 description 5
- 244000018633 Prunus armeniaca Species 0.000 description 5
- 241001290151 Prunus avium subsp. avium Species 0.000 description 5
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 description 5
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 5
- 235000014443 Pyrus communis Nutrition 0.000 description 5
- 240000001987 Pyrus communis Species 0.000 description 5
- 101150090155 R gene Proteins 0.000 description 5
- 241000220259 Raphanus Species 0.000 description 5
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 5
- 240000007651 Rubus glaucus Species 0.000 description 5
- 235000011034 Rubus glaucus Nutrition 0.000 description 5
- 235000009122 Rubus idaeus Nutrition 0.000 description 5
- 240000000111 Saccharum officinarum Species 0.000 description 5
- 235000007201 Saccharum officinarum Nutrition 0.000 description 5
- 241000209056 Secale Species 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 5
- 235000009337 Spinacia oleracea Nutrition 0.000 description 5
- 244000300264 Spinacia oleracea Species 0.000 description 5
- 235000009184 Spondias indica Nutrition 0.000 description 5
- 108091081024 Start codon Proteins 0.000 description 5
- 241001112810 Streptocarpus Species 0.000 description 5
- 235000012308 Tagetes Nutrition 0.000 description 5
- 241000736851 Tagetes Species 0.000 description 5
- 241000723873 Tobacco mosaic virus Species 0.000 description 5
- 102000007641 Trefoil Factors Human genes 0.000 description 5
- 235000015724 Trifolium pratense Nutrition 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 5
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 5
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 5
- 240000001519 Verbena officinalis Species 0.000 description 5
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 5
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 5
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 5
- 241000219873 Vicia Species 0.000 description 5
- 235000002096 Vicia faba var. equina Nutrition 0.000 description 5
- 240000002895 Vicia hirsuta Species 0.000 description 5
- 235000010711 Vigna angularis Nutrition 0.000 description 5
- 240000007098 Vigna angularis Species 0.000 description 5
- 241000863480 Vinca Species 0.000 description 5
- 241000405217 Viola <butterfly> Species 0.000 description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- 235000007244 Zea mays Nutrition 0.000 description 5
- 240000003307 Zinnia violacea Species 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 235000021014 blueberries Nutrition 0.000 description 5
- 210000000081 body of the sternum Anatomy 0.000 description 5
- 235000009120 camo Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 235000005607 chanvre indien Nutrition 0.000 description 5
- 235000019693 cherries Nutrition 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 229930186364 cyclamen Natural products 0.000 description 5
- 230000013020 embryo development Effects 0.000 description 5
- 235000004611 garlic Nutrition 0.000 description 5
- 239000011487 hemp Substances 0.000 description 5
- 229930190166 impatien Natural products 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 235000021374 legumes Nutrition 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000003976 plant breeding Methods 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000015136 pumpkin Nutrition 0.000 description 5
- 230000003938 response to stress Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 235000020354 squash Nutrition 0.000 description 5
- 230000001131 transforming effect Effects 0.000 description 5
- 108700026215 vpr Genes Proteins 0.000 description 5
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 4
- 108020005544 Antisense RNA Proteins 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 4
- 235000018262 Arachis monticola Nutrition 0.000 description 4
- 241000234643 Festuca arundinacea Species 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- 102000005720 Glutathione transferase Human genes 0.000 description 4
- 108010068370 Glutens Proteins 0.000 description 4
- 108091092195 Intron Proteins 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- 241000208467 Macadamia Species 0.000 description 4
- 241000710118 Maize chlorotic mottle virus Species 0.000 description 4
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 4
- 102000048193 Mannose-6-phosphate isomerases Human genes 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 4
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 4
- 235000005205 Pinus Nutrition 0.000 description 4
- 241000218602 Pinus <genus> Species 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 108700005075 Regulator Genes Proteins 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 108090000848 Ubiquitin Proteins 0.000 description 4
- 102000044159 Ubiquitin Human genes 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 101710185494 Zinc finger protein Proteins 0.000 description 4
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 210000003763 chloroplast Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 230000000442 meristematic effect Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 108010058731 nopaline synthase Proteins 0.000 description 4
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 210000001236 prokaryotic cell Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000005562 seed maturation Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 3
- 102100028220 ABI gene family member 3 Human genes 0.000 description 3
- 240000004507 Abelmoschus esculentus Species 0.000 description 3
- 235000004507 Abies alba Nutrition 0.000 description 3
- 235000014081 Abies amabilis Nutrition 0.000 description 3
- 244000101408 Abies amabilis Species 0.000 description 3
- 244000178606 Abies grandis Species 0.000 description 3
- 235000017894 Abies grandis Nutrition 0.000 description 3
- 235000004710 Abies lasiocarpa Nutrition 0.000 description 3
- 240000005020 Acaciella glauca Species 0.000 description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 3
- 244000298697 Actinidia deliciosa Species 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 235000001274 Anacardium occidentale Nutrition 0.000 description 3
- 241000234671 Ananas Species 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 241000686404 Australina Species 0.000 description 3
- 241000218993 Begonia Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000021533 Beta vulgaris Nutrition 0.000 description 3
- 244000178993 Brassica juncea Species 0.000 description 3
- 235000011293 Brassica napus Nutrition 0.000 description 3
- 240000008100 Brassica rapa Species 0.000 description 3
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 3
- 241000220243 Brassica sp. Species 0.000 description 3
- 101100411570 Caenorhabditis elegans rab-28 gene Proteins 0.000 description 3
- 240000006432 Carica papaya Species 0.000 description 3
- 241000269333 Caudata Species 0.000 description 3
- 241000218645 Cedrus Species 0.000 description 3
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 3
- 240000008886 Ceratonia siliqua Species 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- 244000018436 Coriandrum sativum Species 0.000 description 3
- 241000219112 Cucumis Species 0.000 description 3
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 3
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 3
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 3
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 3
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 3
- 244000019459 Cynara cardunculus Species 0.000 description 3
- 235000019106 Cynara scolymus Nutrition 0.000 description 3
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- 235000014466 Douglas bleu Nutrition 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 235000007349 Eleusine coracana Nutrition 0.000 description 3
- 235000013499 Eleusine coracana subsp coracana Nutrition 0.000 description 3
- 244000024675 Eruca sativa Species 0.000 description 3
- 235000014755 Eruca sativa Nutrition 0.000 description 3
- 244000004281 Eucalyptus maculata Species 0.000 description 3
- 241000218218 Ficus <angiosperm> Species 0.000 description 3
- 240000006927 Foeniculum vulgare Species 0.000 description 3
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 3
- 108010001515 Galectin 4 Proteins 0.000 description 3
- 102100039556 Galectin-4 Human genes 0.000 description 3
- 241001315191 Gladiata Species 0.000 description 3
- 101710186898 Globulin 2 Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000000047 Gossypium barbadense Species 0.000 description 3
- 235000009429 Gossypium barbadense Nutrition 0.000 description 3
- 244000299507 Gossypium hirsutum Species 0.000 description 3
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 241000218033 Hibiscus Species 0.000 description 3
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 3
- 101000724234 Homo sapiens ABI gene family member 3 Proteins 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 240000005010 Landoltia punctata Species 0.000 description 3
- 241000219729 Lathyrus Species 0.000 description 3
- 241000339552 Lemna disperma Species 0.000 description 3
- 241000339557 Lemna ecuadoriensis Species 0.000 description 3
- 235000006438 Lemna gibba Nutrition 0.000 description 3
- 241000339996 Lemna obscura Species 0.000 description 3
- 241000339991 Lemna tenera Species 0.000 description 3
- 240000000263 Lemna trisulca Species 0.000 description 3
- 241000339993 Lemna turionifera Species 0.000 description 3
- 241000339987 Lemna valdiviana Species 0.000 description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
- 240000007472 Leucaena leucocephala Species 0.000 description 3
- 241000208682 Liquidambar Species 0.000 description 3
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 3
- 240000005847 Lysimachia japonica Species 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 235000010624 Medicago sativa Nutrition 0.000 description 3
- 235000003805 Musa ABB Group Nutrition 0.000 description 3
- 241001308575 Neglecta Species 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002725 Olea europaea Nutrition 0.000 description 3
- 235000001591 Pachyrhizus erosus Nutrition 0.000 description 3
- 244000215747 Pachyrhizus erosus Species 0.000 description 3
- 235000018669 Pachyrhizus tuberosus Nutrition 0.000 description 3
- 244000038248 Pennisetum spicatum Species 0.000 description 3
- 244000115721 Pennisetum typhoides Species 0.000 description 3
- 244000062780 Petroselinum sativum Species 0.000 description 3
- 244000100170 Phaseolus lunatus Species 0.000 description 3
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 3
- 240000000020 Picea glauca Species 0.000 description 3
- 235000008127 Picea glauca Nutrition 0.000 description 3
- 241000218595 Picea sitchensis Species 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 235000008593 Pinus contorta Nutrition 0.000 description 3
- 241001236219 Pinus echinata Species 0.000 description 3
- 235000005018 Pinus echinata Nutrition 0.000 description 3
- 235000011334 Pinus elliottii Nutrition 0.000 description 3
- 241000142776 Pinus elliottii Species 0.000 description 3
- 244000019397 Pinus jeffreyi Species 0.000 description 3
- 235000017339 Pinus palustris Nutrition 0.000 description 3
- 241000555277 Pinus ponderosa Species 0.000 description 3
- 235000013269 Pinus ponderosa var ponderosa Nutrition 0.000 description 3
- 235000013268 Pinus ponderosa var scopulorum Nutrition 0.000 description 3
- 235000015266 Plantago major Nutrition 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 241000219000 Populus Species 0.000 description 3
- 235000008572 Pseudotsuga menziesii Nutrition 0.000 description 3
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 3
- 241000508269 Psidium Species 0.000 description 3
- 240000001679 Psidium guajava Species 0.000 description 3
- 235000013929 Psidium pyriferum Nutrition 0.000 description 3
- 244000294611 Punica granatum Species 0.000 description 3
- 235000014360 Punica granatum Nutrition 0.000 description 3
- 235000011449 Rosa Nutrition 0.000 description 3
- 235000004789 Rosa xanthina Nutrition 0.000 description 3
- 241000109329 Rosa xanthina Species 0.000 description 3
- 235000017848 Rubus fruticosus Nutrition 0.000 description 3
- 241000209051 Saccharum Species 0.000 description 3
- 244000082988 Secale cereale Species 0.000 description 3
- 241001138418 Sequoia sempervirens Species 0.000 description 3
- 235000008515 Setaria glauca Nutrition 0.000 description 3
- 235000007226 Setaria italica Nutrition 0.000 description 3
- 235000007230 Sorghum bicolor Nutrition 0.000 description 3
- 241000209501 Spirodela Species 0.000 description 3
- 241000500460 Spirodela intermedia Species 0.000 description 3
- 240000000067 Spirodela polyrhiza Species 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 108020005038 Terminator Codon Proteins 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 240000007313 Tilia cordata Species 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 3
- 244000250129 Trigonella foenum graecum Species 0.000 description 3
- 235000019714 Triticale Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 240000003021 Tsuga heterophylla Species 0.000 description 3
- 235000008554 Tsuga heterophylla Nutrition 0.000 description 3
- 241000722923 Tulipa Species 0.000 description 3
- 241000722921 Tulipa gesneriana Species 0.000 description 3
- 101150067314 aadA gene Proteins 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000016520 artichoke thistle Nutrition 0.000 description 3
- 235000000183 arugula Nutrition 0.000 description 3
- 101150103518 bar gene Proteins 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 235000021029 blackberry Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000020226 cashew nut Nutrition 0.000 description 3
- 239000003593 chromogenic compound Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000003184 complementary RNA Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 244000038559 crop plants Species 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 235000004879 dioscorea Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 108010060641 flavanone synthetase Proteins 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 235000021331 green beans Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000014684 lodgepole pine Nutrition 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000014571 nuts Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000002252 panizo Nutrition 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 235000011197 perejil Nutrition 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 235000003499 redwood Nutrition 0.000 description 3
- 235000000673 shore pine Nutrition 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 229960000268 spectinomycin Drugs 0.000 description 3
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000005026 transcription initiation Effects 0.000 description 3
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 241000228158 x Triticosecale Species 0.000 description 3
- 101150016096 17 gene Proteins 0.000 description 2
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 2
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- KKADPXVIOXHVKN-UHFFFAOYSA-N 4-hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=C(O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 240000003870 Ageratum houstonianum Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 235000003276 Apios tuberosa Nutrition 0.000 description 2
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000007558 Avena sp Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- 101150074155 DHFR gene Proteins 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 101710152421 Globulin-1 S allele Proteins 0.000 description 2
- 101710176546 Glucose and ribitol dehydrogenase Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010073032 Grain Proteins Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 235000021506 Ipomoea Nutrition 0.000 description 2
- 241000207783 Ipomoea Species 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000199616 Lingulata Species 0.000 description 2
- 241000209082 Lolium Species 0.000 description 2
- 240000004296 Lolium perenne Species 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000007575 Macadamia integrifolia Species 0.000 description 2
- 241000723994 Maize dwarf mosaic virus Species 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- 235000004456 Manihot esculenta Nutrition 0.000 description 2
- 108091027974 Mature messenger RNA Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 101710091688 Patatin Proteins 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 101710163504 Phaseolin Proteins 0.000 description 2
- 108020005120 Plant DNA Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 238000010847 SEQUEST Methods 0.000 description 2
- 241001106018 Salpiglossis Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 108010043934 Sucrose synthase Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 102100036407 Thioredoxin Human genes 0.000 description 2
- 241000723792 Tobacco etch virus Species 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- 241000482268 Zea mays subsp. mays Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000003390 bioluminescence detection Methods 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000030570 cellular localization Effects 0.000 description 2
- 239000012707 chemical precursor Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000005078 fruit development Effects 0.000 description 2
- 230000004345 fruit ripening Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000005305 organ development Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000000575 proteomic method Methods 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 101150033532 virG gene Proteins 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- HUNCSWANZMJLPM-UHFFFAOYSA-N 5-methyltryptophan Chemical compound CC1=CC=C2NC=C(CC(N)C(O)=O)C2=C1 HUNCSWANZMJLPM-UHFFFAOYSA-N 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 101710187578 Alcohol dehydrogenase 1 Proteins 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- 108010037870 Anthranilate Synthase Proteins 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 108010004539 Chalcone isomerase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 101710190853 Cruciferin Proteins 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000009842 Cucumis melo Nutrition 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 230000026774 DNA mediated transformation Effects 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 101100425275 Dictyostelium discoideum trxC gene Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 101150071673 E6 gene Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000710188 Encephalomyocarditis virus Species 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 101710129170 Extensin Proteins 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 102000009114 Fatty acid desaturases Human genes 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 101710186901 Globulin 1 Proteins 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 101710094577 Glucose and ribitol dehydrogenase homolog Proteins 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 101710115777 Glycine-rich cell wall structural protein 2 Proteins 0.000 description 1
- 101710168683 Glycine-rich protein 1 Proteins 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101800000653 Helper component proteinase Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000899240 Homo sapiens Endoplasmic reticulum chaperone BiP Proteins 0.000 description 1
- 101001132256 Homo sapiens Ras-related protein Rab-28 Proteins 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 241000588744 Klebsiella pneumoniae subsp. ozaenae Species 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010054278 Lac Repressors Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000227653 Lycopersicon Species 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 101710140999 Metallocarboxypeptidase inhibitor Proteins 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 241001045988 Neogene Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010033272 Nitrilase Proteins 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 241000422193 Ormyrus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241001330029 Pooideae Species 0.000 description 1
- 241000053208 Porcellio laevis Species 0.000 description 1
- 241000710078 Potyvirus Species 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 101150041925 RBCS gene Proteins 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 102100034489 Ras-related protein Rab-28 Human genes 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 101100101240 Schizosaccharomyces pombe (strain 972 / ATCC 24843) txl1 gene Proteins 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101710154134 Stearoyl-[acyl-carrier-protein] 9-desaturase, chloroplastic Proteins 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241000187191 Streptomyces viridochromogenes Species 0.000 description 1
- 101710151717 Stress-related protein Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108700025695 Suppressor Genes Proteins 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- 101150096347 TRX3 gene Proteins 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 102100027224 Tumor protein p53-inducible nuclear protein 1 Human genes 0.000 description 1
- 108050003317 Tumor protein p53-inducible nuclear protein 1 Proteins 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108091026828 U2 spliceosomal RNA Proteins 0.000 description 1
- 108091026837 U5 spliceosomal RNA Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 101710196023 Vicilin Proteins 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 108700031584 Zea mays R Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000003529 abscisic acid derivatives Chemical class 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 244000000022 airborne pathogen Species 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 108091010938 auxin binding proteins Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 108010031100 chloroplast transit peptides Proteins 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010961 commercial manufacture process Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 101150029559 hph gene Proteins 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009399 inbreeding Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000009403 interspecific hybridization Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 108010083942 mannopine synthase Proteins 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 101150091879 neo gene Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 101150113864 pat gene Proteins 0.000 description 1
- 108010023506 peroxygenase Proteins 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 102000023888 sequence-specific DNA binding proteins Human genes 0.000 description 1
- 108091008420 sequence-specific DNA binding proteins Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 244000000034 soilborne pathogen Species 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000352 storage cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 101150019416 trpA gene Proteins 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000001419 two-dimensional polyacrylamide gel electrophoresis Methods 0.000 description 1
- 101150101900 uidA gene Proteins 0.000 description 1
- 230000009452 underexpressoin Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000028604 virus induced gene silencing Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 101150074257 xylE gene Proteins 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention generally relates to the field of plant molecular biology, and more specifically to plant genes useful to alter the protein content or level in plants and to develop molecular markers for plant breeding..
- Maize is the world's most widely grown cereal crop and an essential food source for millions ofthe world's poor. More than half of the world's malnourished children live in countries where maize is an important food.
- maize gruel is the main food mothers use to wean their babies, and maize is the single largest source of calories. But babies who subsist on maize can face a dangerous lack of protein during a critical stage of physical and mental development as diets high in maize lack two essential amino acids needed to prevent malnutrition.
- the prolamine (zein) fraction of storage proteins comprises over 50% ofthe total protein in the mature seed, however, ⁇ -zein polypeptides which are especially abundant contain extremely low levels ofthe essential amino acids lysine and tryptophan.
- zein prolamine
- ⁇ -zein polypeptides which are especially abundant contain extremely low levels ofthe essential amino acids lysine and tryptophan.
- maize seed protein is deficient in these amino acids because such a large proportion of the total seed storage protein is contributed by the ⁇ -zeins (Mertz et al., 1964).
- the development of breeding steps to improve maize based on the manipulation of zein profile is hampered by the complexity ofthe zein proteins.
- the term "zein" encompasses a family of some 100 related proteins.
- C-zeins include proteins with molecular weights of 19,000 and 22,000 daltons; 3-zeins include proteins with a molecular weight of 14,000 daltons; ( ⁇ zeins include proteins with molecular weights of 27,000 and 26,000 daltons; and ⁇ -zeins include proteins having a molecular weight of 10,000 daltons.
- the ⁇ -zeins are the major zein proteins found in the endosperm of maize kernels. However, the complexity of zein proteins goes beyond these size classes. Protein sequence analyses indicates that there is microheterogenicity in zein amino acid sequences. This is in accord with isoelectric focusing analyses which show charge differences in zein proteins. Over 70 genes encoding the zein proteins have been identified (Rubenstein, 1982), and the zein genes appear to be located on at least three chromosomes. Thus, the zein proteins are encoded by a multigene family.
- Down regulation of gene expression in a plant may also occur through expression of a particular transgene.
- This type of down regulation is referred to as co-suppression and involves coordinate silencing of a transgene and a second transgene or a homologous endogenous gene (Matzke and Matzke, 1995).
- cosuppression of a herbicide resistance gene in tobacco (Brandle et al., 1995), polygalacturomdase in tomato (Flavell, 1994) and chalcone synthase in petunia (U. S. Patent No. 5,034,323) have been demonstrated.
- Flavell (1994) suggested that multicopy genes, or gene families, must have evolved to avoid cosuppression in order for multiple copies of related genes to be expressed in a plant.
- the new corn variety was prepared which contains nearly twice as much usable protein as other maize grown in the tropics and yields 10 percent more grain.
- the new maize variety called "quality protein maize” (QPM)
- QPM quality protein maize
- the new maize variety was developed through traditional plant breeding and looks and tastes like normal maize, but the nutritive value of its protein is nearly equivalent to cow's milk.
- the varieties produce 70-100 percent more of lysine and tryptophan.
- a bumper crop ofthe maize is expected in the coming months from more than one million hectares (2.5 million acres) currently under cultivation in 11 countries. Economists expect that by 2003, the number of hectares sown to QPM will triple to approximately 3.5 million hectares (8.75 million acres).
- Plants are increasingly used a "protein factories" for production of industrial or therapeutic polypeptides, such as antigens, antibodies (e.g., monoclonal), cytokines, vaccines. Methods for increased yield and/or quality or ease of downstream processing are needed.
- Proteins and genes involved in a tropical high protein trait corn germplasm are disclosed, as well as their use to genetically modify cereals for higher protein yield and better protein quality.
- a total 11 genes (and thir orthologs) are identified for use in protein trait modification in cereals, particularly corn. These genes belong to two groups: one group of proteins is associated with seed protein storage and the other group is generally related to seed stress response or proteins that are unregulated during seed maturation. Possibly the stress response mechanism has co-evolved with the high protein trait. Higher protein yield in com and other cereals can be achieved by manipulating the gene expression level of these genes and other regulatory genes regulating the stress mechanism.
- the invention provides isolated nucleic acid molecules, e.g., DNA, comprising a plant nucleotide sequence encoding a polypeptide that is expressed in cells of a plant, e.g., embryos, mature embryos, endosperm, shoot, root, leaf and developing seed, from high protein varieties of plants, relative to cells of a plant from a corresponding lower protein variety.
- the invention provides a nucleic acid molecule comprising a plant nucleotide sequence comprising an open reading frame encoding a polypeptide which is substantially similar to a polypeptide comprising any one of SEQ ID Nos. 1-36.
- this sequence may be overexpressed individually, in the sense or antisense orientation, or in combination with other sequences, to confer altered nutritional properties to the plant relative to a plant that does not comprise and/or express the sequence(s).
- the protein content may be enhanced, while in another embodiment it may be reduced, e.g., low protein products such as rice for individuals that are intolerant or sensitive to certain proteins.
- Low protein content plants or seeds can be a superior form for production of heterologous industrially or therapeutically important proteins in plants, and plant seeds by, for example, reducing levels of abundant endogenous proteins. To avoid detrimental effects to the plants, such modulation can be controlled using inducible promoters.
- One system employs hybrid two component systems such as Gal4/Cl, in which the controlled promoter(s) is on or off only in the hybrid, not the parental lines.
- the overexpression may be constitutive, or it may be preferable to express the sequence from an inducible promoter including a promoter which is responsive to external stimuli, such as chemical application, or environmental stimuli, so as to avoid possible deleterious effects on plant growth.
- High protein varieties of plants are those which have at least a 1%, preferably at least 5%, and more preferably at least 10%, increase in protein content or level relative to a corresponding control plant.
- a high protein line or variety preferably may have a protein content in whole kernel that is at least 14.5%, more preferably at least 15.5%, in embyro at least 11%, more preferably 18.3%, and in endosperm at least 13.5%, more preferably at least 14.2%>.
- High protein varieties of maize are well known to the art, see, for example, U.S. Patent Nos. 5,986,182, 5,936,143, 5,907,089, 5,900,528, 5,850,031, 5,824,855, 5,824,854, 5,763,756, and 5,675,065.
- protein expression profiles from embryos of normal and high protein varieties of maize were compared using two-dimensional SDS-PAGE analysis in order to identify differentially expressed genes.
- proteomic technology to the high protein corn germplasm has revealed more than 120 genes that are differentially expressed in high protein lines.
- genes may encode structural or regulatory proteins, and hence are of potential use in manipulating protein content in maize (corn) and other cereals such as wheat and rice, e.g., for manipulating seed protein phenotype and for the development of molecular markers for plant breeding.
- the results provide a novel function for unknown or previously uncharacterize ⁇ V mischaracterized genes, and may lead to useful regulatory genes for particular traits, structural genes or molecular markers. Further, by using a segregating population, the results also provide the necessary means to identify genes specifically related to the high protein phenotype rather than those that are merely causally associated.
- the identified proteins (polypeptides) and their corresponding genes can be used to: 1) manipulate protein content or levels in corn and other cereal species, e.g., by using the genes as molecular markers in breeding or in transgenic plants; 2) isolate orthologs from other crop species such as rice and wheat; 3) generate antibodies and develop protein-based assays for breeding selection; and 4) identify common transcriptional regulatory elements and factors which bind those elements, i.e.; the upstream regions ofthe genes associated with the high protein trait.
- Non-protein based methods may also be employed to identify the nucleic acid molecules ofthe invention.
- an array of nucleic acid samples e.g., a plurality of oligonucleotides, each plurality corresponding to a different plant gene, on a solid substrate, e.g., a DNA chip, and probes corresponding to nucleic acid obtained from plant sources that express genes associated with protein content and probes to nucleic acid obtained from plant sources that do not express those genes or express the genes at a reduced level, can be used to systematically identify genes associated with increased protein levels.
- the nucleotide sequence in the nucleic acid molecule ofthe invention is from plant DNA, either a dicot or a monocot, which encodes a polypeptide that is substantially similar to a polypeptide comprising any one of SEQ ID NOs: 1-36. More preferably, the nucleotide sequence is from plant DNA that is substantially similar to a nucleic acid segment encoding a polypeptide comprising any one of SEQ ID NOs: 1-36.
- substantially similar when used herein with respect to a polypeptide means a polypeptide corresponding to a reference polypeptide, wherein the polypeptide has substantially the same structure and function as the reference polypeptide, e.g., where only changes in amino acid sequence are those which do not affect the polypeptide function.
- the percentage of identity between the substantially similar and the reference polypeptide or amino acid sequence is at least 65%, 66%, 67%, 68%, 69%>, 70%, e.g., 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, and even 90% or more, e.g., 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, up to at least 99%o, where the reference polypeptide is a polypeptide comprising any one of SEQ ID NOs: 1-36.
- an agent e.g., an antibody, which specifically binds to one ofthe polypeptides, specifically binds to the other.
- the term “substantially similar”, when used herein with respect to a nucleotide sequence, means a nucleotide sequence corresponding to a reference nucleotide sequence, wherein the corresponding sequence encodes a polypeptide having substantially the same structure and function as the polypeptide encoded by the reference nucleotide sequence.
- the term “substantially similar” is specifically intended to include nucleotide sequences wherein the sequence has been modified to optimize expression in particular cells.
- the percentage of identity between the substantially similar nucleotide sequence and the reference nucleotide sequence is at least 65%, 66%, 67%, 68%, 69%, 70%, e.g., 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, ' 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, and even 90% or more, e.g., 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, up to at least 99%, wherein the reference sequence is one which encodes a polypeptide comprising any one of SEQ ID NOs: 1-36, or the complement thereof.
- Sequence comparisons maybe carried out using a Smith- Waterman sequence alignment algorithm (see e.g. Waterman (1995) or http://www hto.usc.edu/software/seqahi index.html).
- the locals program, version 1.16 is preferably used with following parameters: match: 1, mismatch penalty: 0.33, open-gap penalty: 2, extended-gap penalty: 2.
- nucleotide sequence that is "substantially similar" to a reference nucleotide sequence hybridizes to the reference nucleotide sequence in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in 2X SSC, 0.1% SDS at 50°C, more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in IX SSC, 0.1% SDS at 50°C, more desirably still in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in 0.5X SSC, 0.1% SDS at 50°C, preferably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing
- the isolated nucleic acid molecules ofthe invention also include orthologs of the sequences encoding the polypeptides comprising the amino acid sequences disclosed herein, including, but not limited to, dicots and monocots, preferably cereal plants, e.g., wheat or rice.
- An ortholog is a gene from a different species that encodes a product having the same function as the product encoded by a gene from a reference organism. The encoded ortholog products likely have at least 70%> sequence identity to each other.
- the invention includes an isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide having at least 70%> identity to a polypeptide comprising one or more ofthe sequences disclosed herein.
- GenBank GenBank or one found at http://bioserver.myongjiac.kr/rjce.html (for rice) may be employed to identify sequences related to the disclosed sequences, e.g., orthologs in cereal crops such as rice.
- recombinant DNA techniques such as hybridization or PCR may be employed to identify sequences related to the disclosed sequences.
- the polypeptide has substantial identity, i.e., at least 70%>, e.g., 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, and even 90% or more, e.g., 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, and at least 99%o, amino acid sequence identity to a polypeptide comprising any one of SEQ ID NOs: 1-36.
- the invention also provides anti-sense nucleic acid molecules corresponding to the genes identified herein.
- expression cassettes e.g., recombinant vectors, and host cells, comprising the nucleic acid molecule ofthe invention.
- the nucleic acid molecules ofthe invention are useful to provide plants with enhanced protein content, identify common transcriptional regulatory factors which bind upstream ofthe coding region of genes associated with high protein content and as markers for breeding selection.
- the compositions ofthe invention include plant nucleic acid sequences and the amino acid sequences for the polypeptides or partial-length polypeptides encoded thereby which are useful to provide enhanced nutritional characteristics to a plant, preferably by enhancing protein content or levels.
- Methods ofthe invention involve stably transforming a plant with one or more of at least a portion of these nucleotide sequences operably linked to a promoter capable of driving expression of that nucleotide sequence in a plant cell.
- portion or fragment as it relates to a nucleic acid molecule, sequence or segment ofthe invention, when it is linked to other sequences for expression, is meant a sequence having at least 80 nucleotides, more preferably at least 150 nucleotides, and still more preferably at least 400 nucleotides. If not employed for expressing, a "portion” or “fragment” means at least 9, preferably 12, more preferably 15, even more preferably at least 20, consecutive nucleotides, e.g., probes and primers (oligonucleotides), corresponding to the nucleotide sequence ofthe nucleic acid molecules of the invention.
- the method comprises introducing to a plant, plant cell, or plant tissue an expression cassette comprising at least one of nucleic acid molecules ofthe invention so as to yield a transformed differentiated plant, transformed cell or transformed tissue.
- Transformed cells or tissue can be regenerated to provide a transformed differentiated plant.
- the transformed differentiated plant preferably expresses the nucleic acid molecule in an amount that yields a transformed plant having enhanced protein content, e.g., in seed, to a corresponding nontransformed plant.
- the present invention also provides a transformed plant prepared by the method, progeny and seed thereof.
- a transformed (transgenic) plant ofthe invention includes plants, dicots or monocots, the genome of which is augmented by a nucleic acid molecule ofthe invention, or in which the corresponding gene has been disrupted, e.g., to result in a loss, a decrease or an alteration, in the function ofthe product encoded by the gene.
- the nucleic acid molecules ofthe invention are thus useful for targeted gene disruption, as well as for markers and probes.
- the invention also includes recombinant nucleic acid molecules which have been modified so as to comprise codons other than those present in the unmodified sequence.
- the recombinant nucleic acid molecules ofthe invention include those in which the modified codons specify amino acids that are the same as those specified by the codons in the unmodified sequence, as well as those that specify different amino acids, i.e., they encode a variant polypeptide having one or more amino acid substitutions relative to the polypeptide encoded by the unmodified sequence.
- the invention further includes a nucleotide sequence which is complementary to one (hereinafter "test" sequence) which hybridizes under stringent conditions with the nucleic acid molecules ofthe invention as well as RNA which is encoded by the nucleic acid molecule.
- test sequence a nucleotide sequence which is complementary to one
- RNA which is encoded by the nucleic acid molecule.
- either a denatured test or nucleic acid molecule ofthe invention is preferably first bound to a support and hybridization is effected for a specified period of time at a temperature of, e.g., between 55 and 70°C, in double strength citrate buffered saline (SC) containing 0.1% SDS followed by rinsing ofthe support at the same temperature but with a buffer having a reduced SC concentration.
- SC citrate buffered saline
- SC citrate buffered saline
- a buffer having a reduced SC concentration buffers are typically single strength SC containing 0.1 % SDS, half strength SC containing 0.1% SDS and one-tenth strength SC containing 0.1% SDS.
- the present invention also provides a method to identify a polypeptide which is associated with a high protein phenotype.
- the method comprises separating a plurality of polypeptides from a sample comprising polypeptides, wherein the sample is from a plant having a high protein content. Then the separated sample of polypeptides from a plant having a high protein content is compared to a separated sample of polypeptides from a corresponding plant with lower protein content.
- polypeptides are identified that are present in the sample from a plant having a high protein content that are not present in the sample from the plant with lower protein content.
- nucleic acid molecule comprising a nucleotide sequence that directs transcription, e.g., a promoter, of a linked nucleic acid fragment in a host cell, such as a plant cell.
- the nucleotide sequence is from plant genomic DNA which has at least 65%, 66%, 61%, 68%, 69%, 70%, e.g., 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, and even 90% or more, e.g., 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, and 99%, nucleotide sequence identity to a sequence of a promoter from a plant gene encoding a polypeptide comprising any one of SEQ ID NOs: 1-36.
- the isolated nucleic acid molecule comprises a plant nucleotide sequence which is the promoter region for a gene encoding any one of SEQ ID NOs: 1-36, or is structurally related to the promoter for a gene encoding SEQ ID NOs: 1-36, i.e., is an orthologous promoter, and is linked to a plant structural gene.
- the present invention further provides an expression cassette or a recombinant vector containing the nucleic acid molecule, and the vector may be a plasmid.
- cassettes or vectors when present in a plant, plant cell or plant tissue result in transcription ofthe linked nucleic acid fragment in the plant, plant tissue or plant cell.
- the expression cassettes or vectors ofthe invention may optionally include other regulatory sequences, e.g., transcription terminator sequences, introns and/or enhancers, and may be contained in a host cell.
- the expression cassette or vector may augment the genome of a transformed plant or may be maintained extrachromosomally.
- the expression cassette or vector may further have a Ti plasmid and be contained in an Agrobacterium tumefaciens cell; it may be carried on a microparticle, wherein the microparticle is suitable for ballistic transformation of a plant cell; or it may be contained in a plant cell protoplast.
- the expression cassette can be contained in a plant, plant cell or plant tissue from a dicot or a monocot.
- the plant may be a cereal plant.
- the present invention further provides a method of augmenting a plant genome by contacting plant cells with an expression cassette or vector ofthe invention, i.e., one having a nucleotide sequence that directs transcription ofa linked nucleic acid fragment in a plant cell, wherein the nucleotide sequence is from plant genomic DNA that has at least 65 > , and more preferably at least 70%>, identity to the sequence of a promoter from a gene encoding a polypeptide comprising any one of SEQ ID NOs: 1-36 so as to yield transformed plant cells; and regenerating the transformed plant cells to provide a differentiated transformed plant, wherein the differentiated transformed plant expresses the linked fragment in the cells ofthe plant.
- the present invention also provides a plant prepared by the method, progeny and seed thereof.
- Figure 1 shows the protein content in various sources from high protein and control maize lines.
- Figures 2A and 2B illustrate a two dimensional gel with proteins from a control (#530; panel A) or high protein (#465; panel B) maize line.
- Figures 2C and 2D illustrate another comparision of protein expression profile of high protein germplasm and normal corn line.
- Figures 3A to 3H show the peptide and criteria (e.g., Xcro > 2 and Den > 0.01) employed to search databases for the corresponding full length protein for 18 ofthe proteins shown in the attached Sequence Listing which is incorporated herein.
- criteria e.g., Xcro > 2 and Den > 0.01
- Figures 4A and 4B are representative vectors for over- or under-expression of genes in seed.
- Sequence Listing shows the amino acid sequence of proteins, high protein phenotype genes and proteins, or the orthologs thereof, which are preferentially expressed in high protein maize lines relative to lines with lower protein content.
- Sequences 1 to 36 are the high protein involved proteins. Odd numbered SEQ ID Nos are are protein-encoding orfs and the even numbered SEQ ID NOs are amino acids sequences.
- Sequences 37 to 45 are representative peptides identified by the MS as described in the Examples.
- nucleic acid refers to deoxyribonucleotides or ribonucleotides and polymers thereof in either single- or double-stranded form, composed of monomers (nucleotides) containing a sugar, phosphate and a base which is either a purine or pyrimidine. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides which have similar binding properties as the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides.
- nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (e.g., degenerate codon substitutions) and complementary sequences as well as the sequence explicitly indicated.
- degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (Batzer et al., 1991; Ohtsuka et al, 1985; Rossolini et al., 1994).
- a "nucleic acid fragment" is a fraction ofa given nucleic acid molecule.
- nucleic acid sequence refers to a polymer of DNA or RNA which can be single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers.
- nucleic acid refers to a polymer of DNA or RNA which can be single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers.
- nucleic acid may also be used interchangeably with gene, cDNA, DNA and RNA encoded by a gene.
- an "isolated” or “purified” DNA molecule or an “isolated” or “purified” polypeptide is a DNA molecule or polypeptide that, by the hand of man, exists apart from its native environment and is therefore not a product of nature.
- An isolated DNA molecule or polypeptide may exist in a purified form or may exist in a non-native environment such as, for example, a transgenic host cell.
- an "isolated” or “purified” nucleic acid molecule or protein, or biologically active portion thereof is substantially free of other cellular material, or culture medium when produced by recombinant techniques, or substantially free of chemical precursors or other chemicals when chemically synthesized.
- an "isolated" nucleic acid is free of sequences that naturally flank the nucleic acid (i.e., sequences located at the 5' and 3' ends ofthe nucleic acid) in the genomic DNA ofthe organism from which the nucleic acid is derived.
- the isolated nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb, or 0.1 kb of nucleotide sequences that naturally flank the nucleic acid molecule in genomic DNA ofthe cell from which the nucleic acid is derived.
- a protein that is substantially free of cellular material includes preparations of protein or polypeptide having less than about 30%, 20%,, 10%, 5%, (by dry weight) of contaminating protein.
- culture medium represents less than about 30%, 20%, 10%, or 5%, (by dry weight) of chemical precursors or non-protein-of- interest chemicals.
- Fragments and variants ofthe disclosed nucleotide sequences and proteins or partial-length proteins encoded thereby are also encompassed by the present invention.
- fragment or portion is meant a full length or less than full length ofthe nucleotide sequence encoding, or the amino acid sequence of, a polypeptide or protein.
- fragments or portions ofa nucleotide sequence that are useful as hybridization probes generally do not encode fragment proteins retaining biological activity.
- fragments or portions of a nucleotide sequence may range from at least about 9 nucleotides, about 12 nucleotides, about 20 nucleotides, about 50 nucleotides, about 100 nucleotides or more.
- genes include coding sequences and/or the regulatory sequences required for their expression.
- gene refers to a nucleic acid fragment that expresses mRNA, functional RNA, or specific protein, including regulatory sequences.
- Genes also include nonexpressed DNA segments that, for example, form recognition sequences for other proteins.
- Genes can be obtained from a variety of sources, including cloning from a source of interest or synthesizing from known or predicted sequence information, and may include sequences designed to have desired parameters.
- Naturally occurring is used to describe an object that can be found in nature as distinct from being artificially produced by man.
- a protein or nucleotide sequence present in an organism which can be isolated from a source in nature and which has not been intentionally modified by man in the laboratory, is naturally occurring.
- a "marker gene” encodes a selectable or screenable trait.
- Selectable marker is a gene whose expression in a cell gives the cell a selective advantage.
- the selective advantage possessed by the cells transformed with the selectable marker gene may be due to their ability to grow in the presence of a negative selective agent, such as an antibiotic or a herbicide, compared to the growth of non-transformed cells.
- the selective advantage possessed by the transformed cells, compared to non-transformed cells may also be due to their enhanced or novel capacity to utilize an added compound as a nutrient, growth factor or energy source.
- Selectable marker gene also refers to a gene or a combination of genes whose expression in a cell gives the cell both a negative and/or a positive selective advantage.
- chimeric refers to any gene or DNA that contains 1) DNA sequences, including regulatory and coding sequences, that are not found together in nature, or 2) sequences encoding parts of proteins not naturally adjoined, or 3) parts of promoters that are not naturally adjoined. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or comprise regulatory sequences and coding sequences derived from the same source, but arranged in a manner different from that found in nature.
- transgene refers to a gene that has been introduced into the genome by transformation and is stably maintained.
- Transgenes may include, for example, DNA that is either heterologous or homologous to the DNA of a particular plant to be transformed. Additionally, transgenes may comprise native genes inserted into a non-native organism, or chimeric genes.
- endogenous gene refers to a native gene in its natural location in the genome of an organism.
- a “foreign” gene refers to a gene not normally found in the host organism but that is introduced by gene transfer.
- variants include those sequences that, because ofthe degeneracy ofthe genetic code, encode the identical amino acid sequence ofthe native protein.
- Naturally occurring allelic variants such as these can be identified with the use of well-known molecular biology techniques, as, for example, with polymerase chain reaction (PCR) and hybridization techniques.
- variant nucleotide sequences also include synthetically derived nucleotide sequences, such as those generated, for example, by using site-directed mutagenesis which encode the native protein, as well as those that encode a polypeptide having amino acid substitutions.
- nucleotide sequence variants ofthe invention will have at least 40, 50, 60, to 70%», e.g., preferably 71%>, 72%, 73%, 74%, 75%, 76%, 77%, 78%, to 79%, generally at least 80%, e.g., 81%-84%, at least 85%, e.g., 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, to 98%, sequence identity to the native (endogenous) nucleotide sequence.
- DNA shuffling is a method to introduce mutations or rearrangements, preferably randomly, in a DNA molecule or to generate exchanges of DNA sequences between two or more DNA molecules, preferably randomly.
- the DNA molecule resulting from DNA shuffling is a shuffled DNA molecule that is a non-naturally occurring DNA molecule derived from at least one template DNA molecule.
- the shuffled DNA preferably encodes a variant polypeptide modified with respect to the polypeptide encoded by the template DNA, and may have an altered biological activity with respect to the polypeptide encoded by the template DNA.
- the nucleic acid molecules ofthe invention can be optimized for enhanced expression in plants of interest.
- nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part ofthe gene sequence may be optimized or synthetic. That is, synthetic or partially optimized sequences may also be used. Variant nucleotide sequences and proteins also encompass sequences and protein derived from a mutagenic and recombinogenic procedure such as DNA shuffling.
- one or more different coding sequences can be manipulated to create a new polypeptide possessing the desired properties, hi this manner, libraries of recombinant polynucleotides are generated from a population of related sequence polynucleotides comprising sequence regions that have substantial sequence identity and can be homologously recombined in vitro or in vivo.
- Strategies for such DNA shuffling are known in the art. See, for example, Stemmer (1994); Stemmer (1994); Crameri et al. (1997); Moore et al. (1997); Zhang et al. (1997); Crameri et al. (1998); and U.S. Patent Nos. 5,605,793 and 5,837,458.
- Constantly modified variations of aparticular nucleic acid sequence refers to those nucleic acid sequences that encode identical or essentially identical amino acid sequences, or where the nucleic acid sequence does not encode an amino acid sequence, to essentially identical sequences. Because ofthe degeneracy ofthe genetic code, a large number of functionally identical nucleic acids encode any given polypeptide. For instance the codons CGT, CGC, CGA, CGG, AGA, and AGG all encode the amino acid arginine. Thus, at every position where an arginine is specified by a codon, the codon can be altered to any ofthe corresponding codons described without altering the encoded protein.
- nucleic acid variations are “silent variations” which are one species of “conservatively modified variations.” Every nucleic acid sequence described herein which encodes a polypeptide also describes every possible silent variation, except where otherwise noted.
- each codon in a nucleic acid except ATG, which is ordinarily the only codon for methionine
- each "silent variation" of a nucleic acid which encodes a polypeptide is implicit in each described sequence.
- "Recombinant DNA molecule” is a combination of DNA sequences that are joined together using recombinant DNA technology and procedures used to join together DNA sequences as described, for example, in Sambrook et al.
- heterologous DNA sequence each refer to a sequence that originates from a source foreign to the particular host cell or, if from the same source, is modified from its original form.
- a heterologous gene in a host cell includes a gene that is endogenous to the particular host cell but has been modified through, for example, the use of DNA shuffling.
- the terms also include non- naturally occurring multiple copies of a naturally occurring DNA sequence.
- the terms refer to a DNA segment that is foreign or heterologous to the cell, or homologous to the cell but in a position within the host cell nucleic acid in which the element is not ordinarily found. Exogenous DNA segments are expressed to yield exogenous polypeptides.
- a “homologous” DNA sequence is a DNA sequence that is naturally associated with a host cell into which it is introduced. "Wild-type” refers to the normal gene, or organism found in nature without any known mutation.
- Gene refers to the complete genetic material of an organism.
- Vector is defined to include, inter alia, any plasmid, cosmid, phage or Agrobacterium binary vector in double or single stranded linear or circular form which may or may not be self transmissible or mobilizable, and which can transform prokaryotic or eukaryotic host either by integration into the cellular genome or exist extrachromosomally (e.g., autonomous replicating plasmid with an origin of replication).
- shuttle vectors by which is meant a DNA vehicle capable, naturally or by design, of replication in two different host organisms, which may be selected from actinomycetes and related species, bacteria and eukaryotic (e.g., higher plant, mammalian, yeast or fungal cells).
- Codoning vectors typically contain one or a small number of restriction endonuclease recognition sites at which foreign DNA sequences can be inserted in a determinable fashion without loss of essential biological function ofthe vector, as well as a marker gene that is suitable for use in the identification and selection of cells transformed with the cloning vector. Marker genes typically include genes that provide tetracycline resistance, hygromycin resistance or ampicillin resistance.
- Expression cassette as used herein means a DNA sequence capable of directing expression of a particular nucleotide sequence in an appropriate host cell, comprising a promoter operably linked to the nucleotide sequence of interest which is operably linked to termination signals. It also typically comprises sequences required for proper translation ofthe nucleotide sequence.
- the coding region usually codes for a protein of interest but may also code for a functional RNA of interest, for example antisense RNA or a nontranslated RNA, in the sense or antisense direction.
- the expression cassette comprising the nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components.
- the expression cassette may also be one which is naturally occurring but has been obtained in a recombinant form useful for heterologous expression.
- the expression ofthe nucleotide sequence in the expression cassette may be under the control ofa constitutive promoter or of an inducible promoter which initiates transcription only when the host cell is exposed to some particular external stimulus. In the case ofa multicellular organism, the promoter can also be specific to a particular tissue or organ or stage of development.
- Such expression cassettes will comprise the transcriptional initiation region ofthe invention linked to a nucleotide sequence of interest.
- Such an expression cassette is provided with a plurality of restriction sites for insertion ofthe gene of interest to be under the transcriptional regulation ofthe regulatory regions.
- the expression cassette may additionally contain selectable marker genes.
- the transcriptional cassette will include in the 5'-3' direction of transcription, a transcriptional and translational initiation region, a DNA sequence of interest, and a transcriptional and translational termination region functional in plants.
- the termination region may be native with the transcriptional initiation region, may be native with the DNA sequence of interest, or may be derived from another source.
- Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau et al. (1991); Proudfoot (1991); Sanfacon et al. (1991); Mogen et al. (1990); Munroe et al.
- An oligonucleotide corresponding to a nucleic acid molecule ofthe invention may be about 30 or fewer nucleotides in length (e.g., 9, 12, 15, 18, 20, 21 or 24, or any number between 9 and 30).
- primers are upwards of 14 nucleotides in length.
- primers of 16-24 nucleotides in length may be preferred.
- probing can be done with entire restriction fragments ofthe gene disclosed herein which may be 100's or even 1000's of nucleotides in length.
- Coding sequence refers to a DNA or RNA sequence that codes for a specific amino acid sequence and excludes the non-coding sequences. It may constitute an "uninterrupted coding sequence", i.e., lacking an intron, such as in a cDNA or it may include one or more introns bounded by appropriate splice junctions.
- An "intron” is a sequence of RNA which is contained in the primary transcript but which is removed through cleavage and re-ligation of the RNA within the cell to create the mature mRNA that can be translated into a protein.
- the terms “open reading frame” and “ORF” refer to the amino acid sequence encoded between translation initiation and termination codons of a coding sequence.
- initiation codon and “termination codon” refer to a unit of three adjacent nucleotides ('codon') in a coding sequence that specifies initiation and chain termination, respectively, of protein synthesis (mRNA translation).
- a "functional RNA” refers to an antisense RNA, ribozyme, or other RNA that is not translated.
- RNA transcript refers to the product resulting from RNA polymerase catalyzed transcription of a DNA sequence.
- the primary transcript When the RNA transcript is a perfect complementary copy ofthe DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing ofthe primary transcript and is referred to as the mature RNA.
- Messenger RNA (mRNA) refers to the RNA that is without introns and that can be translated into protein by the cell.
- cDNA refers to a single- or a double-stranded DNA that is complementary to and derived from mRNA.
- Regulatory sequences each refer to nucleotide sequences located upstream (5' non-coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation ofthe associated coding sequence. Regulatory sequences include enhancers, promoters, translation leader sequences, introns, and polyadenylation signal sequences. They include natural and synthetic sequences as well as sequences which may be a combination of synthetic and natural sequences. As is noted above, the term “suitable regulatory sequences” is not limited to promoters. However, some suitable regulatory sequences useful in the present invention will include, but are not limited to constitutive plant promoters, plant tissue-specific promoters, plant development specific promoters, inducible plant promoters and viral promoters.
- 5' non-coding sequence refers to a nucleotide sequence located 5' (upstream) to the coding sequence. It is present in the fully processed mRNA upstream ofthe initiation codon and may affect processing ofthe primary transcript to mRNA, mRNA stability or translation efficiency (Turner et al., 1995).
- 3' non-coding sequence refers to nucleotide sequences located 3' (downstream) to a coding sequence and include polyadenylation signal sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression.
- the polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end ofthe mRNA precursor.
- the use of different 3' non-coding sequences is exemplified by Ingelbrecht et al., 1989.
- translation leader sequence refers to that DNA sequence portion of a gene between the promoter and coding sequence that is transcribed into RNA and is present in the fully processed mRNA upstream (5') ofthe translation start codon.
- the translation leader sequence may affect processing ofthe primary transcript to mRNA, mRNA stability or translation efficiency.
- mature protein refers to a post-translationally processed polypeptide without its signal peptide.
- Precursor protein refers to the primary product of translation of an mRNA.
- Signal peptide refers to the amino terminal extension of a polypeptide, which is translated in conjunction with the polypeptide forming a precursor peptide and which is required for its entrance into the secretory pathway.
- signal sequence refers to a nucleotide sequence that encodes the signal peptide.
- Intracellular localization sequence refers to a nucleotide sequence that encodes an intracellular targeting signal.
- An “intracellular targeting signal” is an amino acid sequence that is translated in conjunction with a protein and directs it to a particular sub- cellular compartment.
- Endoplasmic reticulum (ER) stop transit signal refers to a carboxy- terminal extension of a polypeptide, which is translated in conjunction with the polypeptide and causes a protein that enters the secretory pathway to be retained in the ER.
- ER stop transit sequence refers to a nucleotide sequence that encodes the ER targeting signal.
- Other intracellular targeting sequences encode targeting signals active in seeds and/or leaves and vacuolar targeting signals.
- Promoter refers to a nucleotide sequence, usually upstream (5') to its coding sequence, which controls the expression ofthe coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription.
- Promoter includes a minimal promoter that is a short DNA sequence comprised of a TATA- box and other sequences that serve to specify the site of transcription initiation, to which regulatory elements are added for control of expression.
- Promoter also refers to a nucleotide sequence that includes a minimal promoter plus regulatory elements that is capable of controlling the expression of a coding sequence or functional RNA. This type of promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers.
- an “enhancer” is a DNA sequence which can stimulate promoter activity and may be an innate element ofthe promoter or a heterologous element inserted to enhance the level or tissue specificity of a promoter. It is capable of operating in both orientations (normal or flipped), and is capable of functioning even when moved either upstream or downstream from the promoter. Both enhancers and other upstream promoter elements bind sequence-specific DNA-binding proteins that mediate their effects. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even be comprised of synthetic DNA segments. A promoter may also contain DNA sequences that are involved in the binding of protein factors which control the effectiveness of transcription initiation in response to physiological or developmental conditions.
- the "initiation site” is the position surrounding the first nucleotide that is part ofthe transcribed sequence, which is also defined as position +1. With respect to this site all other sequences ofthe gene and its controlling regions are numbered. Downstream sequences (i.e., further protein encoding sequences in the 3' direction) are denominated positive, while upstream sequences (mostly ofthe controlling regions in the 5' direction) are denominated negative.
- Promoter elements particularly a TATA element, that are inactive or that have greatly reduced promoter activity in the absence of upstream activation are referred to as "minimal or core promoters.”
- the minimal promoter functions to permit transcription.
- a “minimal or core promoter” thus consists only of all basal elements needed for transcription initiation, e.g., a TATA box and/or an initiator.
- Constutive expression refers to expression using a constitutive or regulated promoter.
- Consditional and “regulated expression” refer to expression controlled by a regulated promoter.
- Constant promoter refers to a promoter that is able to express the gene that it controls in all or nearly all ofthe plant tissues during all or nearly all developmental stages of the plant.
- Each ofthe transcription-activating elements do not exhibit an absolute tissue-specificity, but mediate transcriptional activation in most plant parts at a level of >1% ofthe level reached in the part ofthe plant in which transcription is most active.
- Regular promoter refers to promoters that direct gene expression not constitutively, but in a temporally- and/or spatially-regulated manner, and include both tissue-specific and inducible promoters. It includes natural and synthetic sequences as well as sequences which may be a combination of synthetic and natural sequences. Different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. New promoters of various types useful in plant cells are constantly being discovered, numerous examples may be found in the compilation by Okamuro et al. (1989). Since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of different lengths may have identical promoter activity.
- Typical regulated promoters useful in plants include but are not limited to safener-inducible promoters, promoters derived from the tetracycline-inducible system, promoters derived from salicylate-inducible systems, promoters derived from alcohol- inducible systems, promoters derived from glucocorticoid-inducible system, promoters derived from pathogen-inducible systems, and promoters derived from ecdysome-inducible systems.
- tissue-specific promoter refers to regulated promoters that are not expressed in all plant cells but only in one or more cell types in specific organs (such as leaves or seeds), specific tissues (such as embryo or cotyledon), or specific cell types (such as leaf parenchyma or seed storage cells). These also include promoters that are temporally regulated, such as in early or late embryogenesis, during fruit ripening in developing seeds or fruit, in fully differentiated leaf, or at the onset of senescence.
- “Inducible promoter” refers to those regulated promoters that can be turned on in one or more cell types by an external stimulus, such as a chemical, light, hormone, stress, or a pathogen.
- “Operably-linked” refers to the association of nucleic acid sequences on single nucleic acid fragment so that the function of one is affected by the other.
- a regulatory DNA sequence is said to be “operably linked to” or “associated with” a DNA sequence that codes for an RNA or a polypeptide ifthe two sequences are situated such that the regulatory DNA sequence affects expression ofthe coding DNA sequence (i.e., that the coding sequence or functional RNA is under the transcriptional control ofthe promoter). Coding sequences can be operably-linked to regulatory sequences in sense or antisense orientation.
- “Expression” refers to the transcription and/or translation of an endogenous gene or a transgene in plants.
- expression may refer to the transcription ofthe antisense DNA only.
- expression refers to the transcription and stable accumulation of sense (mRNA) or functional RNA. Expression may also refer to the production of protein.
- altered levels refers to the level of expression in transgenic cells or organisms that differs from that of normal or untransformed cells or organisms.
- “Overexpression” refers to the level of expression in transgenic cells or organisms that exceeds levels of expression in normal or untransformed cells or organisms.
- Antisense inhibition refers to the production of antisense RNA transcripts capable of suppressing the expression of protein from an endogenous gene or a transgene.
- Codon and transwitch each refer to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar transgene or endogenous genes (U.S. Patent No. 5,231,020).
- Gene silencing refers to homology-dependent suppression of viral genes, transgenes, or endogenous nuclear genes. Gene silencing may be transcriptional, when the suppression is due to decreased transcription ofthe affected genes, or post-transcriptional, when the suppression is due to increased turnover (degradation) of RNA species homologous to the affected genes. (English et al., 1996). Gene silencing includes virus-induced gene silencing (Ruiz et al., 1998).
- Silencing suppressor gene refers to a gene whose expression leads to counteracting gene silencing and enhanced expression of silenced genes.
- Silencing suppressor genes may be of plant, non-plant, or viral origin. Examples include, but are not limited to HC-Pro, Pl-HC- Pro, and 2b proteins. Other examples include one or more genes in TGMV-B genome.
- Transcription stop fragment refers to nucleotide sequences that contain one or more regulatory signals, such as polyadenylation signal sequences, capable of terminating transcription. Examples include the 3' non-regulatory regions of genes encoding nopaline synthase and the small subunit of ribulose bisphosphate carboxylase.
- Translation stop fragment refers to nucleotide sequences that contain one or more regulatory signals, such as one or more termination codons in all three frames, capable of terminating translation. Insertion of a translation stop fragment adjacent to or near the initiation codon at the 5' end ofthe coding sequence will result in no translation or improper translation. Excision ofthe translation stop fragment by site-specific recombination will leave a site-specific sequence in the coding sequence that does not interfere with proper translation using the initiation codon.
- c ⁇ -acting sequence and "cts-acting element” refer to DNA or RNA sequences whose functions require them to be on the same molecule.
- An example of a cis- acting sequence on the replicon is the viral replication origin.
- trans-acting sequence and "trans-acting element” refer to DNA or RNA sequences whose function does not require them to be on the same molecule.
- Chrosomally-integrated refers to the integration of a foreign gene or DNA construct into the host DNA by covalent bonds. Where genes are not “chromosomally integrated” they may be “transiently expressed.” Transient expression of a gene refers to the expression of a gene that is not integrated into the host chromosome but functions independently, either as part of an autonomously replicating plasmid or expression cassette, for example, or as part of another biological system such as a virus.
- sequence relationships between two or more nucleic acids or polynucleotides are used to describe the sequence relationships between two or more nucleic acids or polynucleotides: (a) “reference sequence”, (b) “comparison window”, (c) “sequence identity”, (d) “percentage of sequence identity”, and (e) “substantial identity”.
- reference sequence is a defined sequence used as a basis for sequence comparison.
- a reference sequence may be a subset or the entirety of a specified sequence; for example, as a segment ofa full length cDNA or gene sequence, or the complete cDNA or gene sequence.
- comparison window makes reference to a contiguous and specified segment of a polynucleotide sequence, wherein the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment ofthe two sequences.
- the comparison window is at least 20 contiguous nucleotides in length, and optionally can be 30, 40, 50, 100, or longer.
- Computer implementations of these mathematical algorithms can be utilized for comparison of sequences to determine sequence identity.
- Such implementations include, but are not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics,
- HSPs high scoring sequence pairs
- Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always > 0) and N (penalty score for mismatching residues; always ⁇ 0).
- M forward score for a pair of matching residues
- N penalty score for mismatching residues; always ⁇ 0.
- a scoring matrix is used to calculate the cumulative score. Extension ofthe word hits in each direction are halted when the cumulative alignment score falls off by the quantity X from its maximum achieved value, the cumulative score goes to zero or below due to the accumulation of one or more negative-scoring residue alignments, or the end of either sequence is reached.
- the BLAST algorithm also performs a statistical analysis ofthe similarity between two sequences (see, e.g., Karlin & Altschul (1993).
- BLAST smallest sum probability
- P(N) the smallest sum probability
- a test nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison ofthe test nucleic acid sequence to the reference nucleic acid sequence is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.
- Gapped BLAST in BLAST
- BLAST 2.0 can be utilized as described in Altschul et al. (1997).
- PSI-BLAST in BLAST 2.0
- PSI-BLAST can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al., supra.
- the default parameters ofthe respective programs e.g. BLASTN for nucleotide sequences, BLASTX for proteins
- the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, 1989). See http://www.ncbi.nlm.nih.gov. Alignment may also be performed manually by inspection.
- comparison of nucleotide sequences for determination of percent sequence identity to the promoter sequences disclosed herein is preferably made using the BlastN program (version 1.4.7 or later) with its default parameters or any equivalent program.
- equivalent program is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by the preferred program.
- sequence identity or “identity” in the context of two nucleic acid or polypeptide sequences makes reference to a specified percentage of residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window, as measured by sequence comparison algorithms or by visual inspection.
- percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties ofthe molecule.
- sequences differ in conservative substitutions the percent sequence identity maybe adjusted upwards to correct for the conservative nature ofthe substitution. Sequences that differ by such conservative substitutions are said to have
- sequence similarity or “similarity.”
- Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated, e.g., as implemented in the program PC/GENE (Litelligenetics, Mountain View, California).
- percentage of sequence identity means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment ofthe two sequences. The percentage is calculated by determining the number of positions at which- the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity.
- polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, or 79%, preferably at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, or 89%, more preferably at least 90%, 91%, 92%, 93%, or 94%, and most preferably at least
- stringent conditions are selected to be about 5°C lower than the thermal melting point (T m ) for the specific sequence at a defined ionic strength and pH.
- stringent conditions encompass temperatures in the range of about 1°C to about 20°C, depending upon the desired degree of stringency as otherwise qualified herein.
- Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical ifthe polypeptides they encode are substantially identical. This may occur, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code.
- One indication that two nucleic acid sequences are substantially identical is when the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the polypeptide encoded by the second nucleic acid.
- substantially identical in the context of a peptide indicates that a peptide comprises a sequence with at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, or 79%, preferably 80%, 81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, or 89%, more preferably at least 90%, 91%, 92%, 93%, or 94%, or even more preferably, 95%, 96%, 97%, 98% or 99%o, sequence identity to the reference sequence over a specified comparison window.
- optimal alignment is conducted using the homology alignment algorithm of Needleman and Wunsch, 1970.
- a peptide is substantially identical to a second peptide, for example, where the two peptides differ only by a conservative substitution.
- sequence comparison typically one sequence acts as a reference sequence to which test sequences are compared.
- test and reference sequences are input into a computer, subsequence coordinates are designated if necessary, and sequence algorithm program parameters are designated.
- sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program parameters.
- hybridizing specifically to refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent conditions when that sequence is present in a complex mixture (e.g., total cellular) DNA or RNA.
- Bod(s) substantially refers to complementary hybridization between a probe nucleic acid and a target nucleic acid and embraces minor mismatches that can be accommodated by reducing the stringency ofthe hybridization media to achieve the desired detection ofthe target nucleic acid sequence.
- Stringent hybridization conditions and “stringent hybridization wash conditions” in the context of nucleic acid hybridization experiments such as Southern and Northern hybridizations are sequence dependent, and are different under different environmental parameters. Longer sequences hybridize specifically at higher temperatures.
- the T m is the temperature (under defined ionic strength and pH) at which 50% ofthe target sequence hybridizes to a perfectly matched probe. Specificity is typically the function of post- hybridization washes, the critical factors being the ionic strength and temperature ofthe final wash solution.
- T m can be approximated from the equation of Meinkoth and Wahl, 1984; T m 81.5°C + 16.6 (log M) +0.41 (%GC) - 0.61 (% form) - 500/L; where M is the molarity of monovalent cations, %>GC is the percentage of guanosine and cytosine nucleotides in the DNA, %> form is the percentage of formamide in the hybridization solution, and L is the length ofthe hybrid in base pairs. T m is reduced by about 1°C for each 1% of mismatching; thus, T m , hybridization, and/or wash conditions canbe adjusted to hybridize to sequences ofthe desired identity.
- the T m can be decreased 10°C.
- stringent conditions are selected to be about 5°C lower than the thermal melting point (T m ) for the specific sequence and its complement at a defined ionic strength and pH.
- a high stringency wash is preceded by a low stringency wash to remove background probe signal.
- An example medium stringency wash for a duplex of, e.g., more than 100 nucleotides, is IX SSC at 45°C for 15 minutes.
- An example low stringency wash for a duplex of, e.g., more than 100 nucleotides, is 4-6X SSC at 40°C for 15 minutes.
- stringent conditions typically involve salt concentrations of less than about 1.5 M, more preferably about 0.01 to 1.0 M, Na ion concentration (or other salts) at pH 7.0 to 8.3, and the temperature is typically at least about 30°C and at least about 60°C for long robes (e.g., >50 nucleotides).
- Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide.
- a signal to noise ratio of 2X (or higher) than that observed for an unrelated probe in the particular hybridization assay indicates detection of a specific hybridization.
- Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical ifthe proteins that they encode are substantially identical. This occurs, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code.
- Very stringent conditions are selected to be equal to the T m for a particular probe.
- An example of stringent conditions for hybridization of complementary nucleic acids which have more than 100 complementary residues on a filter in a Southern or Northern blot is 50% formamide, e.g., hybridization in 50%> formamide, 1 M NaCl, 1% SDS at 37°C, and a wash in 0. IX SSC at 60 to 65°C.
- Exemplary moderate stringency conditions include hybridization in 40 to 45% > formamide, 1.0 M NaCl, 1% SDS at 37°C, and a wash in 0.5X to IX SSC at 55 to 60°C.
- a reference nucleotide sequence preferably hybridizes to the reference nucleotide sequence in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in 2X SSC, 0.1% SDS at 50°C, more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in IX SSC, 0.1%) SDS at 50°C, more desirably still in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C with washing in 0.5X SSC, 0.1% SDS at 50°C, preferably in 7% sodium dode
- variant polypeptide is intended a polypeptide derived from the native protein by deletion (so-called truncation) or addition of one or more amino acids to the N-terminal and/or C-terminal end ofthe native protein; deletion or addition of one or more amino acids at one or more sites in the native protein; or substitution of one or more amino acids at one or more sites in the native protein.
- variants may results form, for example, genetic polymorphism or from human manipulation. Methods for such manipulations are generally known in the art.
- polypeptides ofthe invention maybe altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art.
- amino acid sequence variants ofthe polypeptides can be prepared by mutations in the DNA. Methods for mutagenesis and nucleotide sequence alterations are well known in the art. See, for example, Kunkel (1985); Kunkel et al. (1987); U. S. Patent No. 4,873,192; Walker and Gaastra (1983), and the references cited therein.
- Guidance as to appropriate amino acid substitutions that do not affect biological activity ofthe protein of interest may be found in the model of Dayhoff et al. (1978). Conservative substitutions, such as exchanging one amino acid with another having similar properties, are preferred.
- the genes and nucleotide sequences ofthe invention include both the naturally occurring sequences as well as mutant forms.
- the polypeptides ofthe invention encompass both naturally occurring proteins as well as variations and modified forms thereof. Such variants will continue to possess the desired activity.
- the deletions, insertions, and substitutions ofthe polypeptide sequence encompassed herein are not expected to produce radical changes in the characteristics ofthe polypeptide. However, when it is difficult to predict the exact effect ofthe substitution, deletion, or insertion in advance of doing so, one skilled in the art will appreciate that the effect will be evaluated by routine screening assays.
- Production tissue refers to mature, harvestable tissue consisting of non-dividing, [0 terminally-differentiated cells. It excludes young, growing tissue consisting of germline, meristematic, and not-fully-differentiated cells.
- “Germline cells” refer to cells that are destined to be gametes and whose genetic material is heritable.
- plant refers to any plant, particularly to seed plant
- plant cell is a L5 structural and physiological unit ofthe plant, e.g., a cell which comprises a cell wall or a protoplast.
- the plant cell may be in form of an isolated single cell or a cultured cell, or as a part of higher organized unit such as, for example, a plant tissue, or a plant organ.
- Plant tissue includes differentiated and undifferentiated tissues or plants, including but not limited to roots, stems, shoots, leaves, pollen, seeds, tumor tissue and various forms of 20 cells and culture such as single cells, protoplast, embryos, and callus tissue.
- the plant tissue may be in plants or in organ, tissue or cell culture.
- altered plant trait means any phenotypic or genotypic change in a transgenic plant relative to the wild-type or non-transgenic plant host.
- transgenic refers to the transfer of a nucleic acid fragment into the 5 genome of a host cell, resulting in genetically stable inheritance.
- Host cells containing the transformed nucleic acid fragments are referred to as "transgenic” cells, and organisms comprising transgenic cells are referred to as "transgenic organisms".
- transgenic organisms Examples of methods of transformation of plants and plant cells include Agrobacterium-ms ⁇ atQd transformation (De Blaere et al, 1987) and particle bombardment technology (Klein et al., 1987; U.S. Patent No. 0 4,945,050). Whole plants may be regenerated from transgenic cells by methods well known to the skilled artisan (see, for example, Fromm et al., 1990).
- Transformed refers to a host cell or organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced.
- the nucleic acid molecule can be stably integrated into the genome generally known in the art and are disclosed in Sambrook et al. (1989). See also Innis et al. (1995); and Gelfand (1995); and Innis and Gelfand (1999).
- Known methods of PCR include, but are not limited to, methods using paired primers, nested primers, single specific primers, degenerate primers, 5 gene-specific primers, vector-specific primers, partially mismatched primers, and the like.
- “transformed,” “transformant,” and “transgenic” plants or calli have been through the transformation process and contain a foreign gene integrated into their chromosome.
- the term “untransformed” refers to normal plants that have not been through the transformation process.
- a “transgenic plant” is a plant having one or more plant cells that contain an expression [0 vector.
- Transiently transformed refers to cells in which transgenes and foreign DNA have been introduced (for example, by such methods as Agrobacterium-mediated transformation or biolistic bombardment), but not selected for stable maintenance.
- “Stably transformed” refers to cells that have been selected and regenerated on a L 5 selection media following transformation.
- Transient expression refers to transgene expression in cells, e.g., after transformation with recombinant virus or by such methods as Agrobacterium-mediated transformation, electroporation, or biolistic bombardment, but not selected for its stable maintenance.
- Genetically stable and “heritable” refer to chromosomally-integrated genetic elements 20 that are stably maintained in the plant and stably inherited by progeny through successive generations.
- Primary transformant and “TO generation” refer to transgenic plants that are ofthe same genetic generation as the tissue which was initially transformed (i.e., not having gone through meiosis and fertilization since transformation). 25 “Secondary transformants” and the “Tl, T2, T3, etc. generations” refer to transgenic plants derived from primary transformants through one or more meiotic and fertilization cycles. They may be derived by self-fertilization of primary or secondary transformants or crosses of primary or secondary transformants with other transformed or untransformed plants.
- “Significant increase” is an increase that is larger than the margin of error inherent in 0 the measurement technique, preferably an increase by about 2-fold or greater.
- This invention relates to isolated plant nucleic acid molecules, sequences and segments (fragments), the expression of which is increased in plants with increased protein content or levels, as well as the endogenous plant promoters for those expressed molecules, sequences or segments.
- Preferred sources for the nucleic acid molecules ofthe invention include, but are not limited to, corn (Zea mays), Brassica sp. (e.g., B. napus, B.
- rapa, B.juncea particularly those Brassica species useful as sources of seed oil, alfalfa (Medicago sativa), rice (Ot ⁇ za sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana)), sunflower (Helianthus annuus), safflower
- genus Lemna L. aequinoctialis, L. disperma, L. ecuadoriensis, L. gibba, L. japonica, L. minor, L. miniscula, L. obscura, L. perpusilla, L. tenera, L. trisulca, L. turionifera, L. valdiviana
- genus Spirodela S. intermedia, S. polyrrhiza, S.punctata
- genus Woffia Wa. angusta, Wa. arrhiza, Wa. australina, Wa. borealis, Wa. brasiliensis, Wa. columbiana, Wa.
- Lemnaceae Any other genera or species of Lemnaceae, if they exist, are also aspects ofthe present invention.
- Lemna gibba, Lemna minor, and Lemna miniscula are preferred, vtit . Lemna minor and Lemna miniscula being most preferred.
- Lemna species can be classified using the taxonomic scheme described by Landolt, Biosystematic Investigation on the Family of Duckweeds: The family of Lemnaceae - A Monograph Study. Geobatanischen Institut ⁇ TH, founded Rubel, Zurich (1986)); vegetables including tomatoes (Lycopersicon esculentwn), lettuce (e.g., Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseolus limensis), peas (Lathyrus spp.), and members ofthe genus Cucumis such as cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon (C. melo).
- tomatoes Loxicon esculentwn
- lettuce e.g., Lactuca sativa
- green beans Phaseeolus vulgaris
- lima beans Phaseeolus limensis
- peas Lathyrus spp.
- Ornamentals include azalea (Rhododendron spp.), hydrangea (Macrophylla hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosa spp.), tulips (Tulipa spp.), daffodils (Narcissus spp.), petunias (Petunia hybrida), carnation
- Conifers that may be employed in practicing the present invention include, for example, pines such as loblolly pine (Pinus taeda), slash pine (Pinus elliotii), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata), Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsuga canadensis); Sitka spruce (Picea glauca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabilis) and balsam fir (Abies balsamea); and cedars such as Western red cedar (Thuja plicata) and Alaska yellow-cedar (Chamaecypar
- Leguminous plants include beans and peas.
- Beans include guar, locust bean, fenugreek, soybean, garden beans, cowpea, mungbean, lima bean, fava bean, lentils, chickpea, etc.
- Legumes include, but are not limited to, Arachis, e.g., peanuts, Vicia, e.g., crown vetch, hairy vetch, adzuki bean, mung bean, and chickpea, Lupinus, e.g., lupine, trifolium, Phaseolus, e.g., common bean and lima bean, Pisum, e.g., field bean, Melilotus, e.g., clover, Medicago, e.g., alfalfa, Lotus, e.g., trefoil, lens, e.g., lentil, and false indigo, Acacia, aneth, artichoke, arugula, blackberry, canola, cilantro, Clementines, escarole, eucalyptus, fennel, grapefruit, honey dew, jicama, kiwifruit, lemon, lime, mushroom, nut, okra, orange
- Preferred forage and turf grass nucleic acid sources for use in the methods ofthe invention include alfalfa, orchard grass, tall fescue, perennial ryegrass, creeping bent grass, and redtop.
- the nucleic acid sources are crop plants and in particular cereals (for example, corn, alfalfa, sunflower, rice, Brassica, canola, soybean, barley, soybean, sugarbeet, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, etc.), and even more preferably corn and soybean.
- the present invention is directed to a nucleic acid molecule comprising a nucleotide sequence isolated from any plant which encodes a polypeptide having at least 70% amino acid sequence identity to a polypeptide comprising SEQ ID NOs. 1-36 or a promoter for said nucleotide sequence.
- a nucleic acid molecule comprising a nucleotide sequence isolated from any plant which encodes a polypeptide having at least 70% amino acid sequence identity to a polypeptide comprising SEQ ID NOs. 1-36 or a promoter for said nucleotide sequence.
- orthologs of those sequences may be identified or isolated from the genome of any desired organism, preferably from another plant, according to well known techniques based on their sequence similarity to the coding sequences, e.g., hybridization, PCR or computer generated sequence comparisons.
- genomic DNA fragments or cDNA fragments i.e., genomic or cDNA libraries
- suitable genomic and cDNA libraries may be prepared from any cell or tissue of an organism.
- Such techniques include hybridization screening of plated DNA libraries (either plaques or colonies; see, e.g., Sambrook et al, 1989) and amplification by PCR using oligonucleotide primers preferably corresponding to sequence domains conserved among related polypeptide or subsequences ofthe nucleotide sequences provided herein (see, e.g., Innis et al., 1990). These methods are particularly well suited to the isolation of gene sequences from organisms closely related to the organism from which the probe sequence is derived.
- oligonucleotide primers can be designed for use in PCR reactions to amplify corresponding DNA sequences from cDNA or genomic DNA extracted from any plant of interest. Methods for designing PCR primers and PCR cloning are generally known in the art as discussed hereinabove.
- hybridization techniques all or part of a known nucleotide sequence is used as a probe that selectively hybridizes to other corresponding nucleotide sequences present in a population of cloned genomic DNA fragments or cDNA fragments (i.e., genomic or cDNA libraries) from a chosen organism.
- the hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group such as 32 P, or any other detectable marker.
- probes for hybridization can be made by labeling synthetic oligonucleotides based on the sequence ofthe invention.
- sequences that hybridize to the sequences disclosed herein will have at least 40% to 50%, about 60% to 70% and even about 80% 85%, 90%, 95% to 98% or more identity with the disclosed sequences. That is, the sequence similarity of sequences may range, sharing at least about 40%, to 50%, about 60% to 70%, and even about 80%>, 85%, 90%, 95%> to 98%o sequence similarity.
- nucleic acid molecules ofthe invention can also be identified by, for example, a search of known databases for genes encoding polypeptides having a specified amino acid sequence identity. Methods of alignment of sequences for comparison are well known in the art and are described hereinabove.
- Globulin-1 s allele precursor and Globulin-2 precursor are embryo storage protein. Reference describing these two gene family include (1) Biochem Genet 1989 Apr;27(3-4):239-51 Characterization of embryo globulins encoded by the maize Gib genes. Kriz AL. and (2) Characterization ofthe maize Globulin-2 gene and analysis of two null alleles. Kriz AL, Wallace NH Biochem Genet 1991 Jun;29(5-6):241-54, which are incorporated by reference. Oleosin is a proteins associated with seed oil body.
- Glucose and ribitol dehydrogenase homolog is an embryo-specifc protein, up-regulated during seed maturation, and is further described in Alexander R, Alamillo JM, Salamini F, Bartels D Planta 1994;192(4):519-25
- a novel embryo-specific barley cDNA clone encodes a protein with homologies to bacterial glucose and ribitol dehydrogenase, which is inco ⁇ orated by reference.
- ZMPK1 precursor is a putative receptor protein kinase related to stress response, and further described in Zhang R, Walker JC (1993) Structure and expression ofthe S locus-related genes of maize. Plant Mol Biol 21: 1171-1174, whichis inco ⁇ orated herein by reference.
- Glutathione S-transferase is an enzyme for transferring glutathione to many substrates, including cytotoxic substances, and is further described in Marrs K.A. The function and regulation of glutathione S- transferases in plants, Annu. Rev. Plant Physiol. Plant. Mol. Biol. 1996 , Vol. 47: 127-158, which is inco ⁇ orated herein by reference.
- Thioredoxin dependent peroxidase is an enzyme involved in Antioxidative Defense System, further described in RB Van Huystee, Some Molecular Aspects Of Plant Peroxidase Biosynthetic Studies, Annu. Rev. Plant Physiol. Plant. Mol. Biol. 1987 , Vol. 38 : 205-219, which is inco ⁇ orated herein by reference.
- RAB28 protein is an ABA induced gene, in late embryogenesis in repsponse to water stress, further described in Pla M, Gomez J, Goday A, Pages M Regulation ofthe abscisic acid-responsive gene rab28 in maize viviparous mutants, Mol Gen Genet. 1991 Dec;230(3):394-400, which is incoproated herein by reference.
- Dehydrin dHNl belongs to a group of proteins that are stress induced and involved in stress tolerance, further described in Zeevaart JAD, Creelman RA 1988 Metabolisms and physiology of abscisic acids. Annu Rev Plant Physiol Mol Biol 39:439-473, which is incoproated herein by reference.
- Hydroxymethylglutaryl-CoA reductase which is a key enzyme involved in catalyzing an early reaction unique to isoprenoid biosynthesis., further described in (1) Kato-Emori S, Higashi K, Hosoya K, Kobayashi T, Ezura H. Cloning and characterization ofthe gene encoding 3- hydroxy-3-methylglutaryl coenzyme A reductase in melon (Cucumis melo L. reticulatus). Mol Genet Genomics. 2001 Mar;265(l): 135-42, and (2) Caelles C, Ferrer A, Balcells L, Hegardt FG, Boronat A.
- proteomics approach was used to identify genes that were differentially expressed in high protein corn lines. Over 150 differentially expressed protein spots were identified and analyzed as described in the experimental conditions. Provded herein are genes, their proteins, as shown in the Sequence Listing, and their orthologs, applicable to the methods and compositons ofthe present invention.
- the nature ofthe candidate genes and their potential roles in contributing to the high protein phenotype is presented, however, the inventor is by no means to be limited by any one proposed mechanism.
- proteins positively annotated two groups of proteins are outstanding and are believed to be intimately related to the corn high protein phenotype: one group represents the seed storage proteins, including globulins and oleosin. These major seed protein storage components are believed to directly contribute to the high protein phenotype.
- a second group of proteins can be roughly characterized as stress related proteins, such as the heat shock protein, dehydrin and a regulatory gene rab28 involved in ABA related stress response. These two groups of proteins or genes are part ofthe same mechanism that contributes to the high protein yield.
- ABI3 which is a Arabidopsis gene that involved in seed storage protein biosynthesis, is reported as a key player in temperature stress.
- One hypothesis for this relationship is that plants that are more stress resistant, such as more heat tolerant, will grow better, therefore have more grain yield including grain protein.
- other global regulators that have a significant impact on stress related response can be used to manipulate seed protein content, such as the ABI3 from Arabidopsis and its homolog in rice, and in particular the genes ofthe present invention.
- Seed storage proteins directly contribute to the high protein phenotype.
- Antibodies developed against the two embryo specific globulin proteins, glbl and 2 were used to deterimine that their protein levels in the high protein inbred lines are significantly higher than in the control line (1.5-2 fold).
- Gene expression patterns of selected genes were studied in rice gene expression profiling experiments.
- Both seed protein content and protein quality can be changed by using these genes, hi one embodiment a transgenic approach to over express or down regulate these genes in the seeds can be employed to increase grain protein content. Meanwhile, as is evident from their amino acid sequences (see Sequence Listing), some of these genes and proteins are biased to a special amino acid profile, over expressing of these proteins in seed can change the seed protein property. In particular, nutrionally enhanced seed, more complete or elevated in one or more amino acids, can be obtained. For example, poultry, like swine, have a specific amino acid that, if deficient, will reduce the animal's performance on the feed. For poultry, the limiting amino acid is methionine, while for swine the limiting amino acid is lysine. Accordingly, the present invention can provide feed that contains, or can be formulated to contain, an increase in the amount of methionine (or lysine for swine) and general protein to keep the desired protein gross energy ratio in the diet.
- genes disclosed herein are useful as genetic markers in marker assisted breeding programs to select high protein lines during plant breeding.
- antibodies to the proteins ofthe invention for use in ELISA for example
- DNA markers that are linked to these genes, or the genes themselves find use to predict genomic profile and thus trait outcome of siblings in breeding practices.
- the genes and proteins find use in production of effective protein production factories. For example, down regulation of one or more ofthe proteins can provide a seed that is reduced in these proteins thus allowing increased cellular resources for expression of industrially or therapeutically important polypeptides. This can best be done by inducible regulation o the one or more genes. In one embodiment reduction of storage protein content is achieved by anti-sense, for example RNAi methods.
- a two component Gal4/Cl system can be used to provide an inducible system. Two components in separate inbred lines are inactive, but create hybrids in which gene mosulation is activated to create plants with lower protein yield. This methd also finds use to create low protein lines that are less aller genie.
- the present invention also encompasses expression cassettes, preferably in the form of a recombinant vectors comprising the nucleic acid sequences ofthe invention.
- the expression cassette comprises regulatory elements for expression ofthe nucleotide sequences in a host cell capable of expressing the nucleotide sequences.
- regulatory elements usually comprise promoter and termination signals and preferably also comprise elements allowing efficient translation of polypeptides encoded by the nucleic acid sequences ofthe present invention.
- sequences adjacent to the initiating methionine may require modification. For example, they can be modified by the inclusion of sequences known to be effective in plants.
- Vectors comprising the nucleic acid sequences are usually capable of replication in particular host cells, e.g., as extrachromosomal molecules, and are therefore used to amplify the nucleic acid sequences of this invention in the host cells.
- host cells for such vectors are plant cells.
- promoters shown to be functional in plants are driven by promoters shown to be functional in plants.
- the choice of promoter will vary depending on the temporal and spatial requirements for expression, and also depending on the target species, hi many cases, expression in multiple tissues is desirable.
- many promoters from dicotyledons have been shown to be operational in monocotyledons and vice versa, ideally dicotyledonous promoters are selected for expression in dicotyledons, and monocotyledonous promoters for expression in monocotyledons.
- promoters include, but are not limited to, constitutive, inducible, temporally regulated, developmentally regulated, chemically regulated, stress-responsive, tissue-preferred and tissue-specific promoters.
- Promoter sequences are known to be strong or weak.
- a strong promoter provides for a high level of gene expression, whereas a weak promoter provides for a very low level of gene expression.
- An inducible promoter is a promoter that provides for the turning on and off of gene expression in response to an exogenously added agent, or to an environmental or developmental stimulus.
- a bacterial promoter such as the P tac promoter can be induced to varying levels of gene expression depending on the level of isothiopropylgalactoside added to the transformed bacterial cells.
- An isolated promoter sequence that is a strong promoter for heterologous nucleic acid is advantageous because it provides for a sufficient level of gene expression to allow for easy detection and selection of transformed cells and provides for a high level of gene expression when desired.
- Preferred promoters that are expressed constitutively include promoters from genes encoding actin or ubiquitin and the CaMN 35S and 19S promoters.
- the nucleotide sequences of this invention can also be expressed under the regulation of promoters that are chemically regulated. This enables the nucleic acid sequence or encoded polypeptide to be synthesized only when the crop plants are treated with the inducing chemicals.
- Preferred technology for chemical induction of gene expression is detailed in the published application EP 0 332 104 (to Ciba-Geigy) and U.S. Patent 5,614,395.
- a preferred promoter for chemical induction is the tobacco PR- la promoter.
- Tissue-specific or tissue-preferential promoters useful in the present invention are also useful.
- promoters which confer seed-specific expression such as those disclosed by Schemthaner et al. (1988); anther (tapetal) specific promoter B6 (Huffman et al.); and pistil- specific promoters such as a modified S13 promoter (Dzelkalns et al., 1993).
- Preferred tissue specific expression patterns include green tissue-specific, root-specific, stem-specific, and flower-specific. Promoters suitable for expression in green tissue include many which regulate genes involved in photosynthesis and many of these have been cloned from both monocotyledons and dicotyledons.
- a preferred promoter is the maize PEPC promoter from the phosphoenol carboxylase gene (Hudspeth & Grula, 1989).
- a preferred promoter for root-specific expression is that described by de Framond (1991; EP 0 452 269 to Ciba-Geigy).
- a preferred stem specific promoter is that described in U.S. Patent No. 5,625,136 (to Ciba-Geigy) and which drives expression ofthe maize trpA gene. -
- promoters which direct specific or enhanced expression in certain plant tissues will be known to those of skill in the art in light ofthe present disclosure. These include, for example, the rbcS promoter, specific for green tissue; the ocs, nos, and m ⁇ s promoters which have higher activity in roots or wounded leaf tissue; a truncated (-90 to +8) 35S promoter which directs enhanced expression in roots, an tubulin gene that directs expression in roots and promoters derived from zein storage protein genes which direct expression in endosperm.
- ocs octopine synthase
- Preferred plant promoters include, but are not limited to, a promoter such as the CaMV 35S promoter, an enhanced 35S promoter or others such as CaMV 19S, nos, Adhl, sucrose synthase, V-tubulin, ubiquitin, actin, cab, PEPCase or those associated with the R gene complex.
- a promoter such as the CaMV 35S promoter, an enhanced 35S promoter or others such as CaMV 19S, nos, Adhl, sucrose synthase, V-tubulin, ubiquitin, actin, cab, PEPCase or those associated with the R gene complex.
- promoters may include the U2 and U5 snRNA promoters from maize, the promoter from alcohol dehydrogenase, the Z4 promoter from a gene encoding the Z4 22 kD zein protein, the Z10 promoter from a gene encoding a 10 kD zein protein, a Z27 promoter from a gene encoding a 27 kD zein protein, the A20 promoter from the gene encoding a 19 kD -zein protein, inducible promoters, such as the light inducible promoter derived from the pea rbcS gene and the actin promoter from rice; seed specific promoters, such as the phaseolin promoter from beans, may also be used.
- Other promoters useful in the practice ofthe invention are known to those of skill in the art.
- tissue specific promoters which have been described include the lectin (Vodkin, 1983; Lindstrom et al., 1990,) corn alcohol dehydrogenase 1 (Vogel et al., 1992; Demiis et al, 1984), com light harvesting complex (Simpson, 1985; Bansal et al., 1992), corn heat shock protein (Odell et al., 1985; Rochester et al., 1986), pea small subunit RuBP carboxylase (Poulsen et al., 1986; Cashmore et al., 1983), Ti plasmid mannopine synthase (Langridge et al., 1989), Ti plasmid nopaline synthase (Langridge et al., 1989), petunia chalcone isomerase (vanTunen et al., 1988), bean glycine rich protein 1 (Keller et al., 1989), truncated CaMV 35s (Odell
- Inducible promoters that have been described include the ABA- and turgor-inducible promoters, the promoter ofthe auxin-binding protein gene (Schwob et al., 1993), the UDP glucose flavonoid glycosyl-transferase gene promoter (Ralston et al., 1988), the MPI proteinase inhibitor promoter (Cordero et al., 1994), and the glyceraldehyde-3-phosphate dehydrogenase gene promoter (Kohler et al., 1995; Quigley et al., 1989; Martinez et al., 1989).
- tissue-specific regulated genes and/or promoters have been reported in plants. These include genes encoding the seed storage proteins (such as napin, cruciferin, beta- conglycinin, and phaseolin) zein or oil body proteins (such as oleosin), or genes involved in fatty acid biosynthesis (including acyl carrier protein, stearoyl-ACP desaturase. and fatty acid desaturases (fad 2-1)), and other genes expressed during embryo development (such as Bce4, see, for example. EP 255378 and Kridl et al., 1991). Particularly useful for seed-specific expression is the pea vicilin promoter (Czako et al., 1992). (See also U.S. Pat. No.
- cDNA clones that are preferentially expressed in cotton fiber have been isolated (John et al., 1992).
- cDNA clones from tomato displaying differential expression during fruit development have been isolated and characterized (Mansson et al., 1985, Slater et al., 1985).
- the promoter for polygalacturonase gene is active in fruit ripening.
- the polygalacturonase gene is described in U.S. Patent No. 4,535,060, U.S. Patent No. 4,769,061, U.S. Patent No. 4,801,590, and U.S. Patent No. 5,107,065, which disclosures are inco ⁇ orated herein by reference.
- tissue-specific promoters include those that direct expression in leaf cells following damage to the leaf (for example, from chewing insects), in tubers (for example, patatin gene promoter), and in fiber cells (an example of a developmentally-regulated fiber cell protein is E6 (John et al., 1992). The E6 gene is most active in fiber, although low levels of transcripts are found in leaf, ovule and flower.
- tissue-specificity of some "tissue-specific" promoters may not be absolute and may be tested by one skilled in the art using the diphtheria toxin sequence.
- tissue-specific expression with "leaky” expression by a combination of different tissue-specific promoters (Beals et al., 1997).
- Other tissue-specific promoters can be isolated by one skilled in the art (see U.S. 5,589,379).
- Several inducible promoters (“gene switches") have been reported. Many are described in the review by Gatz (1996 and 1997).
- RNA transcript that interferes with translation ofthe mRNA ofthe native DNA sequence.
- Other elements include those that can be regulated by endogenous or exogenous agents, e.g., by DNA binding proteins such as zinc finger proteins, including naturally occurring zinc finger proteins or chimeric zinc finger proteins (see, e.g., U.S. Patent No. 5,789,538, WO 99/48909; WO 99/45132; WO 98/53060; WO 98/53057; WO 98/53058; WO 00/23464; WO 95/19431 ; and WO 98/54311) or myb-like transcription factors.
- DNA binding proteins such as zinc finger proteins, including naturally occurring zinc finger proteins or chimeric zinc finger proteins (see, e.g., U.S. Patent No. 5,789,538, WO 99/48909; WO 99/45132; WO 98/53060; WO 98/53057; WO 98/53058; WO 00/23464; WO 95/19431 ; and WO 98/54311) or myb-
- a chimeric zinc finger protein may include amino acid sequences which bind to a specific DNA sequence (the zinc finger) and amino acid sequences that activate (e.g., GAL 4 sequences) or repress the transcription ofthe sequences linked to the specific DNA sequence.
- amino acid sequences that bind to a specific DNA sequence the zinc finger
- amino acid sequences that activate e.g., GAL 4 sequences
- repress the transcription ofthe sequences linked to the specific DNA sequence e.g., GAL 4 sequences
- Transcriptional terminators are responsible for the termination of transcription and correct mRNA polyadenylation.
- the 3N nontranslated regulatory DNA sequence preferably includes from about 50 to about 1,000, more preferably about 100 to about 1,000, nucleotide base pairs and contains plant transcriptional and translational termination sequences. Appropriate transcriptional terminators and those which are known to function in
- 3 plants include the CaMV 35S terminator, the tml terminator, the nopaline synthase terminator, the pea rbcS E9 terminator, the terminator for the T7 transcript from the octopine synthase gene of Agrobacterium tumefaciens, and the 3N end ofthe protease inhibitor I or II genes from potato or tomato, although other 3N elements known to those of skill in the art can also be employed.
- the 5N regulatory region ofthe expression cassette may also include other enhancing sequences. Numerous sequences have been found to enhance gene expression in transgenic plants. These include sequences which have been shown to enhance expression such as intron sequences (e.g., from Adhl, bronzel or the sucrose synthase intron) and viral leader sequences (e.g., from TMV, MCMV and AMV). For example, a number of non-translated leader
- leader sequences from Tobacco Mosaic Virus TMV
- MCMV Maize Chlorotic Mottle Virus
- AMV Alfalfa Mosaic Virus
- Other leaders known in the art include but are not limited to: Picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5
- TEV leader Tobacco Etch Virus
- MDMV leader Maize Dwarf Mosaic Virus
- Human immunoglobulin heavy-chain binding protein (BiP) leader Macejak et al., 1991
- C. Targeting Sequences for example, TEV leader (Tobacco Etch Virus) (Allison et al., 1986); MDMV leader (Maize Dwarf Mosaic Virus); Human immunoglobulin heavy-chain binding protein (BiP) leader, (Macejak et al., 1991); Untranslated leader from the coat protein
- the nucleotide sequences o the present invention may be target expression of different cellular localizations in the plant. In some cases, localization in the cytosol may be desirable, whereas in other cases, localization in some subcellular organelle, e.g., the nucleus, may be preferred. Subcellular localization of transgene encoded enzymes is undertaken using techniques well known in the art. Typically, the DNA encoding the target peptide from a known organelle-targeted gene product is manipulated and fused upstream of the nucleotide sequence. Many such target sequences are known for the chloroplast and their functioning in heterologous constructions has been shown. The expression ofthe nucleotide sequences ofthe present invention is also targeted to the endoplasmic reticulum or to the vacuoles ofthe host cells. Techniques to achieve this are well-known in the art.
- Marker genes are genes that impart a distinct phenotype to cells expressing the marker gene and thus allow such transformed cells to be distinguished from cells that do not have the marker.
- Such genes may encode either a selectable or screenable marker, depending on whether the marker confers a trait which one can 'select' for by chemical means, i.e., through the use of a selective agent (e.g., a herbicide, antibiotic, or the like), or whether it is simply a trait that one can identify through observation or testing, i.e., by 'screening' (e.g., the R-locus trait).
- a selective agent e.g., a herbicide, antibiotic, or the like
- 'screening' e.g., the R-locus trait
- selectable or screenable marker genes are also genes which encode a "secretable marker” whose secretion can be detected as a means of identifying or selecting for transformed cells. Examples include markers which encode a secretable antigen that can be identified by antibody interaction, or even secretable enzymes which can be detected by their catalytic activity.
- Secretable proteins fall into a number of classes, including small, diffusible proteins detectable, e.g., by ELISA; small active enzymes detectable in extracellular solution (e.g., V-amylase, ⁇ -lactamase, phosphinothricin acetyltransferase); and proteins that are inserted or trapped in the cell wall (e.g., proteins that include a leader sequence such as that found in the expression unit of extensin or tobacco PR-S).
- small, diffusible proteins detectable e.g., by ELISA
- small active enzymes detectable in extracellular solution e.g., V-amylase, ⁇ -lactamase, phosphinothricin acetyltransferase
- proteins that are inserted or trapped in the cell wall e.g., proteins that include a leader sequence such as that found in the expression unit of extensin or tobacco PR-S.
- a gene that encodes a polypeptide that becomes sequestered in the cell wall, and which polypeptide includes a unique epitope is considered to be particularly advantageous.
- a secreted antigen marker would ideally employ an epitope sequence that would provide low background in plant tissue, a promoter-leader sequence that would impart efficient expression and targeting across the plasma membrane, and would produce protein that is bound in the cell wall and yet accessible to antibodies.
- a normally secreted wall protein modified to include a unique epitope would satisfy all such requirements.
- Possible selectable markers for use in connection with the present invention include, but are not limited to, a neo gene, which codes for kanamycin resistance and can be selected for using kanamycin, G418, a gene encoding resistance to bleomycin, and the like; a bar gene which codes for bialaphos resistance; a gene which encodes an altered EPSP synthase protein thus conferring glyphosate resistance; a nitrilase gene such as bxn from Klebsiella ozaenae which confers resistance to bromoxynil; a mutant acetolactate synthase gene (ALS) which confers resistance to imidazolinone, sulfonylurea or other ALS -inhibiting chemicals (European Patent Application 154,204, 1985); a methotrexate-resistant DHFR gene; a dalapon dehalogenase gene that confers resistance to the herbicide dalapon; or a mutated anthranilate synthase
- a mutant EPSP synthase gene is employed, additional benefit may be realized through the inco ⁇ oration of a suitable chloroplast transit peptide, CTP (European Patent Application 0 218 571*, 1987).
- CTP chloroplast transit peptide
- An illustrative embodiment of a selectable marker gene capable of being used in systems to select transformants is the genes that encode the enzyme phosphinothricin acetyltransferase, such as the bar gene from Streptomyces hygroscopicus or the pat gene from Streptomyces viridochromogenes (U.S. Patent No. 5,550,318).
- PPT phosphinothricin acetyltransferase
- Screenable markers that may be employed include, but are not limited to, a 5- glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known; an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues; a -lactamase gene, which encodes an enzyme for which various chromogenic substrates are known (e.g., PAD AC, a chromogenic cephalosporin); xylE gene which encodes a catechol dioxygenase that can convert chromogenic catechols; an -amylase gene; a tyrosinase gene which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone which in turn condenses to form the easily detectable compound melanin; a -galactosidase gene, which encodes an enzyme for which there are chromogenic substrates;
- the R gene complex in maize encodes a protein that acts to regulate the production of anthocyanin pigments in most seed and plant tissue.
- Maize strains can have one, or as many as four, R alleles which combine to regulate pigmentation in a developmental and tissue specific manner.
- a gene from the R gene complex was applied to maize transformation, because the expression of this gene in transformed cells does not harm the cells. Thus, an R gene introduced into such cells will cause the expression of a red pigment and, if stably inco ⁇ orated, can be visually scored as a red sector.
- a maize line carries dominant alleles for genes encoding the enzymatic intermediates in the anthocyanin biosynthetic pathway (C2, Al, A2, Bzl and Bz2), but carries a recessive allele at the R locus, transformation of any cell from that line with R will result in red pigment formation.
- Exemplary lines include Wisconsin 22 which contains the rg-Stadler allele and TR112, a K55 derivative which is r-g, b, PL
- any genotype of maize can be utilized ifthe CI and R alleles are introduced together.
- a further screenable marker contemplated for use in the present invention is firefly luciferase, encoded by the lux gene.
- the presence ofthe lux gene in transformed cells may be detected using, for example, X-ray film, scintillation counting, fluorescent spectrophotometry, low-light video cameras, photon counting cameras or multiwell luminometry. It is also envisioned that this system may be developed for populational screening for bioluminescence, such as on tissue culture plates, or even for whole plant screening.
- a vector ofthe invention can also further comprise plasmid DNA.
- Plasmid vectors include additional DNA sequences that provide for easy selection, amplification, and transformation ofthe expression cassette in prokaryotic and eukaryotic cells, e.g., pUC-deriVed vectors such as pUC8, pUC9, pUCl 8, pUC19, pUC23, pUCl 19, and pUC120, pSK-derived vectors, pGEM-derived vectors, pSP-derived vectors, or pBS-derived vectors.
- the additional DNA sequences include origins of replication to provide for autonomous replication ofthe vector, additional selectable marker genes, preferably encoding antibiotic or herbicide resistance, unique multiple cloning sites providing for multiple sites to insert DNA sequences or genes encoded in the expression cassette, and sequences that enhance transformation of prokaryotic and eukaryotic cells.
- Another vector that is useful for expression in both plant and prokaryotic cells is the binary Ti plasmid (as disclosed in Schilperoort et al., U.S. Patent No. 4,940,838) as exemplified by vector pGA582.
- This binary Ti plasmid vector has been previously characterized by An, cited supra.
- This binary Ti vector can be replicated in prokaryotic bacteria such as E. coli and Agrobacterium.
- the Agrobacterium plasmid vectors can be used to transfer the expression cassette to dicot plant cells, and under certain conditions to monocot cells, such as rice cells.
- the binary Ti vectors preferably include the nopaline T DNA right and left borders to provide for efficient plant cell transformation, a selectable marker gene, unique multiple cloning sites in the T border regions, the colEl replication of origin and a wide host range replicon.
- the binary Ti vectors carrying an expression cassette ofthe invention can be used to transform both prokaryotic and eukaryotic cells, but is preferably used to transform dicot plant cells.
- Virtually any DNA may be used for delivery to recipient cells to ultimately produce fertile transgenic plants in accordance with the present invention.
- DNA segments in the form of vectors and plasmids, or linear DNA fragments, in some instance containing only the DNA element to be expressed in the plant, and the like, may be employed.
- Vectors, plasmids, cosmids, YACs (yeast artificial chromosomes) and DNA segments for use in transforming such cells will, of course, generally comprise the cDNA, gene or genes which one desires to introduce into the cells. These DNA constructs can further include structures such as promoters, enhancers, polylinkers, or even regulatory genes as desired.
- the DNA segment or gene chosen for cellular introduction will often encode a protein which will be expressed in the resultant recombinant cells, such as will result in a screenable or selectable trait and/or which will impart an improved phenotype to the regenerated plant. However, this may not always be the case, and the present invention also encompasses transgenic plants inco ⁇ orating non-expressed transgenes.
- the expression cassettes ofthe present invention can be introduced into a host cell, e.g., a plant cell, in a number of art-recognized ways. Those skilled in the art will appreciate that the choice of method might depend on the type of cell, e.g., monocotyledonous or dicotyledonous, targeted for transformation.
- Vectors which may be used to transform plant tissue with the expression cassettes ofthe present invention include both Agrobacterium vectors and ballistic vectors, as well as vectors suitable for DNA-mediated transformation, e.g., direct uptake or via electroporation. However, cells other than plant cells may be transformed with the expression cassettes ofthe invention.
- Suitable methods of transforming plant cells include, but are not limited to, microinjection (Crossway et al., 1986), direct DNA transfer to plant cells by PEG precipitation; liposomes; electroporation (Riggs et al., 1986, Agrobacteriwn-mediated transformation (Hinchee et al., 1988), direct gene transfer (Paszkowski et al., 1984), and ballistic particle acceleration using devices available from Agracetus, Inc., Madison, Wis. and BioRad, Hercules, Calif, (see, for example, Sanford et al., U.S. Pat. No. 4,945,050; and McCabe et al., 1988).
- a nucleotide sequence ofthe present invention is directly transformed into the plastid genome.
- Plastid transformation technology is extensively described in U.S. Patent Nos. 5,451,513, 5,545,817, and 5,545,818, in PCT application no. WO 95/16783, and in McBride et al., 1994.
- the basic technique for chloroplast transformation involves introducing regions of cloned plastid DNA flanking a selectable marker together with the gene of interest into a suitable target tissue, e.g., using biolistics or protoplast transformation (e.g., calcium chloride or PEG mediated transformation).
- the 1 to 1.5 kb flanking regions facilitate orthologous recombination with the plastid genome and thus allow the replacement or modification of specific regions ofthe plastome.
- point mutations in the chloroplast 16S rRNA and ⁇ sl2 genes conferring resistance to spectinomycin and/or streptomycin are utilized as selectable markers for transfonnation (Svab et al., 1990; Staub et al., 1992). This resulted in stable homoplasmic transformants at a frequency of approximately one per 100 bombardments of target leaves. The presence of cloning sites between these markers allowed creation of a plastid targeting vector for introduction of foreign genes (Staub et al., 1993).
- Plastid expression in which genes are inserted by orthologous recombination into all ofthe several thousand copies of the circular plastid genome present in each plant cell, takes advantage of the enormous copy number advantage over nuclear-expressed genes to permit expression levels that can readily exceed 10%o ofthe total soluble plant protein, hi a preferred embodiment, a nucleotide sequence ofthe present invention is inserted into a plastid targeting vector and transformed into the plastid genome of a desired plant host. Plants homoplastic for plastid genomes containing a nucleotide sequence ofthe present invention are obtained, and are preferentially capable of high expression ofthe nucleotide sequence.
- Agrobacterium tumefaciens cells containing a vector comprising an expression cassette ofthe present invention, wherein the vector comprises a Ti plasmid are useful in methods of making transformed plants. Plant cells are infected with an Agrobacterium tumefaciens as described above to produce a transformed plant cell, and then a plant is regenerated from the transformed plant cell. Numerous Agrobacterium vector systems useful in carrying out the present invention are known. For example, U.S. Pat. No. 4,459,355 discloses a method for transforming susceptible plants, including dicots, with an Agrobacterium strain containing the Ti plasmid. The transformation of woody plants with an Agrobacterium vector is disclosed in U.S. Patent No. 4,795,855.
- U.S. Patent No. 4,940,838 to Schilperoort et al. discloses a binary Agrobacterium vector (i.e., one in which the Agrobacterium contains one plasmid having the vir region of a Ti plasmid but no T region, and a second plasmid having a T region but no vir region) useful in carrying out the present invention. It is particularly preferred to use the binary type vectors of Ti and Ri plasmids of Agrobacterium spp.
- Ti-derived vectors transform a wide variety of higher plants, including monocotyledonous and dicotyledonous plants, such as soybean, cotton, rape, tobacco, and rice (Pacciotti et al., 1985: Byrne et al., 1987; Sukhapinda et al., 1987; Lorz et al., 1985; Potrykus, 1985; Park et al., 1985 : Hiei et al., 1994.
- the use of T-DNA to transform plant cells has received extensive study and is amply described (EP 120516; Hoekema, 1985; Knauf, et al., 1983; and An. et al., 1985.
- the nucleotide sequences ofthe invention can be inserted into binary vectors as described in the examples.
- Transformation of plants can be undertaken with a single DNA molecule or multiple DNA molecules (i.e., co-transformation), and both these techniques are suitable for use with the expression cassettes ofthe present invention.
- Numerous transformation vectors are available for plant transformation, and the expression cassettes of this invention can be used in conjunction with any such vectors. The selection of vector will depend upon the preferred transformation technique and the target species for transformation.
- Preferred plant cells for transformation include, but are not limited to, cells from plant such as com (Zea mays), Brassica sp. (e.g., B. napus, B. rapa, B.
- juncea particularly those Brassica species useful as sources of seed oil, alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana)), sunflower (Helianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanuts (Arachis hypogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatus), cassava (Matiihot esculent
- genus Lemna L. aequinoctialis, L. disperma, L. ecuadoriensis, L. gibba, L. japonica, L. minor, L. miniscida, L. obscura, L. perpusilla, L. tenera, L. trisulca, L. turionifera, L. valdiviana
- genus Spirodela S. intermedia, S. polyrrhiza, S.punctata
- genus Woffia Wa. angusta, Wa. arrhiza, Wa. australina, Wa. borealis, Wa. brasiliensis, Wa. columbiana, Wa.
- Lemnaceae Any other genera or species of Lemnaceae, if they exist, are also aspects ofthe present invention. Lemna gibba, Lemna minor, and Lemna miniscula are preferred, with Lemna minor and Lemna miniscula being most preferred.
- Lemna species can be classified using the taxonomic scheme described by Landolt, Biosystematic Investigation on the Family of Duckweeds: The family of Lemnaceae - A Monograph Study. Geobatanischen Institut ETH, founded Rubel, Zurich (1986)); vegetables including tomatoes (Lycopersicon esculentum), lettuce (e.g., Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseolus limensis), peas (Lathyrus spp.), and members ofthe genus Cucumis such as cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon (C. melo).
- tomatoes Loxicon esculentum
- lettuce e.g., Lactuca sativa
- green beans Phaseeolus vulgaris
- lima beans Phaseeolus limensis
- peas Lathyrus spp.
- Ornamentals include azalea (Rhododendron spp.), hydrangea (M ⁇ crophyll ⁇ hydrangea), hibiscus (Hibiscus rosasaj ensis), roses (Rosa spp.), tulips (Tulipa spp.), daffodils (Narcissus spp.), petunias (Petunia hybrida), carnation (Dianthus caryophyllus), poinsettia (Euphorbia pulcherrima), and chrysanthemum.
- Conifers that may be employed in practicing the present invention include, for example, pines such as loblolly pine (Pinus taeda), slash pine (Pinus elliotii), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata), Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsuga canadensis); Sitka spruce (Picea glauca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabilis) and balsam fir (Abies balsamea); and cedars such as Western red cedar (Thuja plicata) and Alaska yellow-cedar (Chamaecyparis nootkatensis).
- pines such as loblolly pine (Pinus taeda), slash pine (P
- Leguminous plants include beans and peas.
- Beans include guar, locust bean, fenugreek, soybean, garden beans, cowpea, mungbean, lima bean, fava bean, lentils, chickpea, etc.
- Legumes include, but are not limited to, Arachis, e.g., peanuts, Vicia, e.g., crown vetch, hairy vetch, adzuki bean, mung bean, and chickpea, Lupinus, e.g., lupine, trifolium, Phaseolus, e.g., common bean and lima bean, Pisum, e.g., field bean, Melilotus, e.g., clover, Medicago, e.g., alfalfa, Lotus, e.g., trefoil, lens, e.g., lentil, and false indigo, Acacia, aneth, artichoke, arugula, blackberry, canola, cilantro, Clementines, escarole, eucalyptus, fennel, grapefruit, honey dew, jicama, kiwifruit, lemon, lime, mushroom, nut, okra, orange
- Preferred forage and turf grass for use in the methods ofthe invention include alfalfa, orchard grass, tall fescue, perennial ryegrass, creeping bent grass, and redtop.
- plants or cells to be transformed are crop plants and in particular cereals (for example, corn, alfalfa, sunflower, rice, Brassica, canola, soybean, barley, soybean, sugarbeet, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, and the like), and even more preferably rice, corn and soybean.
- cereals for example, corn, alfalfa, sunflower, rice, Brassica, canola, soybean, barley, soybean, sugarbeet, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, and the like
- rice, corn and soybean for example, corn, alfalfa, sunflower, rice, Brassica, canola, soybean, barley, soybean, sugarbeet, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, and the like
- the transformed host cells are monocot or dicot cells, including, but not limited to, wheat, corn (maize), rice, oat, barley, millet, rye, rape and alfalfa, as well as asparagus, tomato, egg plant, apple, pear, quince, cherry, apricot, pepper, melon, lettuce, cauliflower, Brassica, e.g., broccoli, cabbage, brussels sprout, sugar beet, sugar cane, sweetcorn, onion, carrot, leek, cucumber, tobacco, aubergine, beet, broad bean, carrot, celery, chicory, cotton, radish, pumpkin, hemp, buckwheat, orchardgrass, creeping bent top, redtop, ryegrass, tobacco, turfgrass, tall fescue, cow pea, endive, gourd, grape, raspberry, chenopodium, blueberry, pineapple, avocado, mango, banana, groundnut, nectarine, papaya, garlic, pea, peach,
- the transformed host cells are monocot cells such as maize, rice, wheat, barley, oats, and sorghum, which can be regenerated into a transgenic plant.
- Any plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis, may be transformed with a vector ofthe present invention.
- organogenesis means a process by which shoots and roots are developed sequentially from meristematic centers;
- embryogenesis means a process by which shoots and roots develop together in a concerted fashion (not sequentially), whether from somatic cells or gametes.
- tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristems, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem).
- tissue source for transformation will depend on the nature ofthe host plant and the transformation protocol.
- Useful tissue sources include callus, suspension culture cells, protoplasts, leaf segments, stem segments, tassels, pollen, embryos, hypocotyls, tuber segments, meristematic regions, and the like.
- the tissue source is selected and transformed so that it retains the ability to regenerate whole, fertile plants following transformation, i.e., contains totipotent cells.
- Type I or Type II embryonic maize callus and immature embryos are preferred Zea mays tissue sources. Selection of tissue sources for transformation of monocots is described in PCT publication WO 95/06128. For certain plant species, different antibiotic or herbicide selection markers may be preferred.
- Selection markers used routinely in transformation include the nptll gene which confers resistance to kanamycin and related antibiotics (Messing & Vierra, 1982); Bevan et al., 1983), the bar gene which confers resistance to the herbicide phosphinothricin (White et al., 1990, Spencer et al., 1990), the hph gene which confers resistance to the antibiotic hygromycin (Blochinger & Diggelmann), and the dhfr gene, which confers resistance to methotrexate (Bourouis et al., 1983).
- the present invention also provides a transformed (transgenic) plant cell, in planta or explanta, including, but not limited to, a transformed plant cell from plants such as corn (Zea mays), Brassica sp. (e.g., B. napus, B. rapa, B.
- a transformed plant cell from plants such as corn (Zea mays), Brassica sp. (e.g., B. napus, B. rapa, B.
- juncea particularly those Brassica species useful as sources of seed oil, alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana)), sunflower (Helianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanuts (Arachis hypogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatas), cassava (Manihot esc
- genus Lemna L. aequinoctialis, L. disperma, L. ecuadoriensis, L. gibba, L. japonica, L. minor, L. miniscula, L. obscura, L. perpusilla, L. tenera, L. trisulca, L. turionifera, L. valdiviana
- genus Spirodela S. intermedia, S. polyrrhiza, S.punctata
- genus Woffia Wa. angusta, Wa. arrhiza, Wa. australina, Wa. borealis, Wa. brasiliensis, Wa. columbiana, Wa.
- Lemnaceae Any other genera or species of Lemnaceae, if they exist, are also aspects ofthe present invention. Lemna gibba, Lemna minor, and Lemna miniscula are preferred, with Lemna minor and Lemna miniscula being most preferred.
- Lemna species can be classified using the taxonomic scheme described by Landolt, Biosystematic Investigation on the Family of Duckweeds: The family of Lemnaceae - A Monograph Study. Geobatanischen Institut ETH, founded Rubel, Zurich (1986)); vegetables including tomatoes (Lycopersicon esculentum), lettuce (e.g., Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseolus limensis), peas (Lathyrus spp.), and members ofthe genus Cucumis such as cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon (C. melo).
- tomatoes Loxicon esculentum
- lettuce e.g., Lactuca sativa
- green beans Phaseeolus vulgaris
- lima beans Phaseeolus limensis
- peas Lathyrus spp.
- Ornamentals include azalea (Rhododendron spp.), hydrangea (M ⁇ crophyll ⁇ hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosa spp.), tulips (Tulipa spp.), daffodils (Narcissus spp.), petunias (Petunia hybrida), carnation (Dianthus caryophyllus), poinsettia (Euphorbia pulcherrima), and chrysanthemum.
- Conifers that may be employed in practicing the present invention include, for example, pines such as loblolly pine (Pinus t ⁇ ed ⁇ ), slash pine (Pinus elliotii), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata), Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsuga canadensis); Sitka spruce (Picea glauca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabilis) and balsam fir (Abies balsamea); and cedars such as Western red cedar (Thuja plicata) and Alaska yellow-cedar (Chamaecyparis nootkatensis).
- pines such as loblolly pine (Pinus t ⁇ ed ⁇ ), slash pine (P
- Leguminous plants include beans and peas.
- Beans include guar, locust bean, fenugreek, soybean, garden beans, cowpea, mungbean, lima bean, fava bean, lentils, chickpea, etc.
- Legumes include, but are not limited to, Arachis, e.g., peanuts, Vicia, e.g., crown vetch, hairy vetch, adzuki bean, mung bean,, and chickpea, Lupinus, e.g., lupine, trifolium, Phaseolus, e.g., common bean and lima bean, Pisum, e.g., field bean, Melilotus, e.g., clover, Medicago, e.g., alfalfa, Lotus, e.g., trefoil, lens, e.g., lentil, and false indigo, Acacia, aneth, artichoke, arugula, blackberry, canola, cilantro, Clementines, escarole, eucalyptus, fennel, grapefruit, honey dew, jicama, kiwifruit, lemon, lime, mushroom, nut, okra,
- the transformed plants include, but are not limited to, transformed wheat, com (maize), rice, oat, barley, millet, rye, rape and alfalfa, as well as asparagus, tomato, egg plant, apple, pear, quince, cherry, apricot, pepper, melon, lettuce, cauliflower, Brassica, e.g., broccoli, cabbage, brussels sprout, sugar beet, sugar cane, sweetcorn, onion, carrot, leek, cucumber, tobacco, aubergine, beet, broad bean, carrot, celery, chicory, cotton, radish, pumpkin, hemp, buckwheat, orchardgrass, creeping bent top, redtop, ryegrass, tobacco, turfgrass, tall fescue, cow pea, endive, gourd, grape, raspberry, chenopodium, blueberry, pineapple, avocado, mango, banana, groundnut, nectarine, papaya, garlic, pea, peach, peanut, pepper, pineapple
- assays include, for example, “molecular biological” assays well known to those of skill in the art, such as Southern and Northern blotting, in situ hybridization and nucleic acid-based amplification methods such as PCR or RT-PCR; "biochemical” assays, such as detecting the presence ofa protein product, e.g., by immunological means (ELISAs and Western blots) or by enzymatic function; plant part assays, such as leaf or root assays; and also, by analyzing the phenotype of the whole regenerated plant, e.g., for disease or pest resistance.
- DNA may be isolated from cell lines or any plant parts to determine the presence ofthe preselected nucleic acid segment through the use of techniques well known to those skilled in the art. Note that intact sequences will not always be present, presumably due to rearrangement or deletion of sequences in the cell.
- nucleic acid elements introduced through the methods of this invention may be determined by polymerase chain reaction (PCR). Using this technique discreet fragments of nucleic acid are amplified and detected by gel electrophoresis. This type of analysis permits one to determine whether a preselected nucleic acid segment is present in a stable transformant, but does not prove integration ofthe introduced preselected nucleic acid segment into the host cell genome. In addition, it is not possible using PCR techniques to determine whether transformants have exogenous genes introduced into different sites in the genome, i.e., whether transformants are of independent origin. It is contemplated that using PCR techniques it would be possible to clone fragments ofthe host genomic DNA adjacent to an introduced preselected DNA segment.
- PCR polymerase chain reaction
- Positive proof of DNA integration into the host genome and the independent identities of transformants maybe determined using the technique of Southern hybridization. Using this technique specific DNA sequences that were introduced into the host genome and flanking host DNA sequences can be identified. Hence the Southern hybridization pattern of a given transformant serves as an identifying characteristic of that transformant. In addition it is possible through Southern hybridization to demonstrate the presence of introduced preselected DNA segments in high molecular weight DNA, i.e., confirm that the introduced preselected DNA segment has been integrated into the host cell genome.
- the technique of Southern hybridization provides information that is obtained using PCR, e.g., the presence ofa preselected DNA segment, but also demonstrates integration into the genome and characterizes each individual transformant.
- Both PCR and Southern hybridization techniques can be used to demonstrate transmission of a preselected DNA segment to progeny.
- the characteristic Southern hybridization pattern for a given transformant will segregate in progeny as one or more Mendelian genes (Spencer et al., 1992); Laursen et al., 1994) indicating stable inheritance ofthe gene.
- the nonchimeric nature ofthe callus and the parental transformants (R 0 ) was suggested by germline transmission and the identical Southern blot hybridization patterns and intensities ofthe transforming DNA in callus, R 0 plants and Ri progeny that segregated for the transformed gene.
- RNA may only be expressed in particular cells or tissue types and hence it will be necessary to prepare RNA for analysis from these tissues.
- PCR techniques may also be used for detection and quantitation of RNA produced from introduced preselected DNA segments. In this application of PCR it is first necessary to reverse transcribe RNA into DNA, using enzymes such as reverse transcriptase, and then through the use of conventional PCR techniques amplify the DNA. h most instances PCR techniques, while useful, will not demonstrate integrity ofthe RNA product. Further information about the nature ofthe RNA product may be obtained by Northern blotting. This technique will demonstrate the presence of an RNA species and give information about the integrity of that RNA.
- RNA species can also be determined using dot or slot blot Northern hybridizations. These techniques are modifications of Northern blotting and will only demonstrate the presence or absence of an RNA species. While Southern blotting and PCR may be used to detect the preselected DNA segment in question, they do not provide information as to whether the preselected DNA segment is being expressed. Expression may be evaluated by specifically identifying the protein products ofthe introduced preselected DNA segments or evaluating the phenotypic changes brought about by their expression.
- Assays for the production and identification of specific proteins may make use of physical-chemical, structural, functional, or other properties ofthe proteins.
- Unique physical- chemical or structural properties allow the proteins to be separated and identified by electrophoretic procedures, such as native or denaturing gel electrophoresis or isoelectric focussing, or by chromatographic techniques such as ion exchange or gel exclusion chromatography.
- the unique structures of individual proteins offer opportunities for use of specific antibodies to detect their presence in formats such as an ELISA assay. Combinations of approaches may be employed with even greater specificity such as Western blotting in which antibodies are used to locate individual gene products that have been separated by electrophoretic techniques. Additional techniques may be employed to absolutely confirm the identity ofthe product of interest such as evaluation by amino acid sequencing following purification. Although these are among the most commonly employed, other procedures may be additionally used.
- Assay procedures may also be used to identify the expression of proteins by their functionality, especially the ability of enzymes to catalyze specific chemical reactions involving specific substrates and products. These reactions may be followed by providing and quantifying the loss of substrates or the generation of products ofthe reactions by physical or chemical procedures. Examples are as varied as the enzyme to be analyzed.
- bioassays Very frequently the expression of a gene product is determined by evaluating the phenotypic results of its expression. These assays also may take many forms including but not limited to analyzing changes in the chemical composition, mo ⁇ hology, or physiological properties ofthe plant. Mo ⁇ hological changes may include greater stature or thicker stalks. Most often changes in response of plants or plant parts to imposed treatments are evaluated under carefully controlled conditions termed bioassays.
- an expression cassette ofthe invention may be propagated in that species or moved into other varieties ofthe same species, particularly including commercial varieties, using traditional breeding techniques.
- Particularly preferred plants ofthe invention include the agronomically important crops listed above.
- the genetic properties engineered into the transgenic seeds and plants described above are passed on by sexual reproduction and can thus be maintained and propagated in progeny plants.
- the present invention also relates to a transgenic plant cell, tissue, organ, seed or plant part obtained from the transgenic plant. Also included within the invention are transgenic descendants ofthe plant as well as transgenic plant cells, tissues, organs, seeds and plant parts obtained from the descendants.
- the expression cassette in the transgenic plant is sexually transmitted.
- the coding sequence is sexually transmitted through a complete normal sexual cycle ofthe R0 plant to the Rl generation.
- the expression cassette is expressed in the cells, tissues, seeds or plant of a transgenic plant in an amount that is different than the amount in the cells, tissues, seeds or plant of a plant which only differs in that the expression cassette is absent.
- the transgenic plants produced herein are thus expected to be useful for a variety of commercial and research pu ⁇ oses.
- Transgenic plants can be created for use in traditional agriculture to possess traits beneficial to the grower (e.g., agronomic traits such as resistance to water deficit, pest resistance, herbicide resistance or increased yield), beneficial to the consumer ofthe grain harvested from the plant (e.g., improved nutritive content in human food or animal feed), or beneficial to the food processor (e.g., improved processing traits), h such uses, the plants are generally grown for the use of their grain in human or animal foods.
- other parts ofthe plants including stalks, husks, vegetative parts, and the like, may also have utility, including use as part of animal silage or for ornamental proposes.
- chemical constituents e.g., oils or starches
- transgenic plants may be created which have enhanced or modified levels of such components.
- Transgenic plants may also find use in the commercial manufacture of proteins or other molecules, where the molecule of interest is extracted or purified from plant parts, seeds, and the like.
- Cells or tissue from the plants may also be cultured, grown in vitro, or fermented to manufacture such molecules.
- the transgenic plants may also be used in commercial breeding programs, or may be crossed or bred to plants of related crop species. Improvements encoded by the expression cassette may be transferred, e.g., from maize cells to cells of other species, e.g., by protoplast fusion.
- the transgenic plants may have many uses in research or breeding, including creation of new mutant plants through insertional mutagenesis, in order to identify beneficial mutants that might later be created by traditional mutation and selection.
- An example would be the introduction of a recombinant DNA sequence encoding a transposable element that may be used for generating genetic variation.
- the methods ofthe invention may also be used to create plants having unique "signature sequences" or other marker sequences which can be used to identify proprietary lines or varieties.
- the transgenic plants and seeds according to the invention can be used in plant breeding which aims at the development of plants with improved properties conferred by the expression cassette, such as tolerance of viruses or other pests, or other stresses.
- the various breeding steps are characterized by well-defined human intervention such as selecting the lines to be crossed, directing pollination ofthe parental lines, or selecting appropriate descendant plants. Depending on the desired properties different breeding measures are taken.
- the relevant techniques are well known in the art and include but are not limited to hybridization, inbreeding, backcross breeding, multiline breeding, variety blend, interspecific hybridization, aneuploid techniques, etc.
- Hybridization techniques also include the sterilization of plants to yield male or female sterile plants by mechanical, chemical or biochemical means. Cross pollination of a male sterile plant with pollen of a different line assures that the genome ofthe male sterile but female fertile plant will unifonnly obtain properties of both parental lines.
- transgenic seeds and plants according to the invention can be used for the breeding of improved plant lines which for example increase the effectiveness of conventional methods such as herbicide or pesticide treatment or allow to dispense with said methods due to their modified genetic properties.
- new crops with improved stress tolerance can be obtained which, due to their optimized genetic "equipment", yield harvested product of better quality than products which were not able to tolerate comparable adverse developmental conditions.
- High protein com lines Wil500, WU578, WIO4605, control lines (WICY530 and LH59) and a segregating population derived from cross LH59XWIL578 (total of 53 lines) were obtained from Wilson Genetics.
- High protein maize refers to germplasm having elevated levels of protein in the seed, typically above 14.5 % in the whole kernel, above 17%> in the embryo and above 13.5% in the endosperm (see Figure 1).
- proteomic approaches 1) extraction of proteins from tissue including total kernels, mature/developing embyros, root and leaf from 2 week old seedlings, optionally exposed to fertilizer; 2) two-dimensional (2-D) separation of proteins by size and charge using gels using isoelectric focusing (IEF) and SDS-PAGE at three pH ranges (e.g., pH 3-10, pH 4-7 and pH 7-10); 3) image analysis of silver stained gels to identify differentially expressed proteins (by visual inspection and PDQUEST software); 4) gel excision and trypsin digestion of selected protein spots;
- the IEF strips were re-equilibrated with a solution (2% SDS, 50 mM Tris, pH 6.9, 10% glycerol and 7 mM urea), and directly applied to a BioRad 8- 16%) gradient SDS-PAGE gel for electrophoresis.
- the resultant gels were stained with silver using a BioRad silver staining kit according to the manufacturer's recommendations. 2D PAGE profiles were laser scanned and comparative analyses were performed using PDQuest software package (BioRad) . Only spots that were present/completely absent between normal and high protein lines were selected for further analysis. Protein spots were cut out ofthe gel either manually or using the BioRad spot cutter.
- FIG. 2 is an example of two gels, one with proteins from control maize embryos (pH 5-8, spots 13-18, panel A) and another with proteins from a high protein line (pH 5-8, spots 1-12, panel B).
- Figures 2C and 2D are further examples, in which the arrow points to a readily identifiable difference area that contains the various forms of globulins proteins in embryo as described in the invention.
- Figures 3 A to 3H show a subset ofthe 38 proteins which were identified using different criteria (Xcorr and dCN). This genetic information is useful for marker development for breeding pu ⁇ oses in maize and for seed protein content manipulation in cereals in general.
- Relative gene expression levels were determined and are presented in Table 2. All three genes were up regulated in the time course of rice seed development. The gene expression levels were determined by hybridizing the rice mRNA isolated at various developmental stages to an Affymetrix gene chip containing rice gene sequences. The rice genechip covered about 20,000 rice genes. A similar pattern of gene experession during corn seed maturation si expected.
- Taqman analysis for key candidate gene expression was performed as follows. For one step RT-PCR amplification, total RNA was used in a 50 ml reaction using the master mixture of a Taq-Man One-Step RT-PCR Mix Reagnets (cat # 4309169, lot# 0006014) (PE Biosystems, Foster City, CA), following the manufacturer's protocol. The one step RT-PCR was conducted with an ABI Prism* 7900 HT Sequence Detection System (AB Applied Biosystems, Foster City, CA). The reactions were incubated for 30 min at 48° C for reverse transcription, and for 40 cycles of 15 s at 95° C, 60 s at 60° C for amplification. The ramp rate was set at 100% between two different temperature set points.
- 50 ml Reaction was composed of 6.25 ml of 2 mM forward primer, AtTRX3-F (gtgtggaaatgacacagattgtga), 6.25 ml of 2 mM reverse primer, AtTRX3-R (agacgggtgcaatgaaacg), 6.25 ml of 2 mM TaqMan probe (6FAM- agacttcactgcaacatggtgcccac-TAMRA), AtTRX3_TaqMan, 1.25 ml of 40x MultiScribe & Rnase inhibitor Mix, 5 ml of template RNA (50 ng total RNA), and 25 ml of Master Mix w/o UNG (Taq-Man One-Step RT-PCR Mix Reagnets: cat # 4309169, lot# 0006014) (PE Biosystems, Foster City, CA).
- Modulation of high protein trait by genes ofthe invention is readily determined using plant transformation sytems as described herein and as known in the art.
- the Gateway cloning system was used to introduce genes ofthe invention into agrotransformation vectors for cereals, with seed specific promoters. See Figures 4A and 4B.
- the embryo specific promoter is a globulin promoter
- the ADPGPP gene promoter is used as the endosperm specific promoter. Use of these promoter constructs allows ease of cloning various genes under the control of these promoter to overexpress and/or downregulate the expression of these genes.
- Gateway System cloning of ⁇ OPT003 & pOPT004 was as follows. Two oligos (NJ001 for & NJ002rev) were designed to amplify the Gateway Cassette A. These oligos contain restriction enzymes (Bel I and Spe I) to clone into Xba I and BamH I sites ofthe pNON4000 and p ⁇ OV4002 vector (note that Xba I is compatible with Spe I site and Bel I is compatible with BamH I site). The sGFP-M5 gene ofthe pNOV4000 and pNOV4002 plasmid is replaced with the Gateway cassette A in which we generated pOPTOOl and pOPT002 vector.
- pOPTOOl, pOPT002 and pNOV2117 (agro) vector were digested and ligated with Kpn I and Hind in sites. The final products were transformed into DB3.1 E.Coli cells, and the pOPT003 and pOPT004 vectors were generated, as shown in the figures.
- Protein determination was done as follows. For green house generated materials, seed protein were determined by elemental analysis, nitrogen to caculate the total protein yield, using conversion factor 6.25. A N/protein analyzer, FLASH EA 1112 Series , from CE Instruments were used in our experiment. Protein content for field generated seed materials were determined by NTR (Near Infrared) analysis.
- Example 6 5 Vector construction for overexpression and gene "knockout” experiments.
- Nectors used for expression of full-length genes ofthe embodiments ofthe invention of interest in plants are designed to overexpress the protein of interest and are of two general types, biolistic and binary, depending on the plant transformation method to be ) used.
- biolistic transformation For biolistic vectors, the requirements are as follows:
- a gene expression cassette consisting of a promoter (eg. ZmUBIint MOD), the gene of interest (typically, a full-length cD ⁇ A) and a transcriptional terminator (eg. Agrobacterium tumefaciens nos terminator);
- a plant selectable marker cassette consisting of a promoter (eg. rice ActlD-BN MOD), selectable marker gene (eg. phosphomannose isomerase, PMI) and
- transcriptional terminator eg. CaMV terminator
- Vectors designed for transformation by Agrobacterium tumefaciens consist of:
- Vectors designed for reducing or abolishing expression ofa single gene or of a family or related genes are also of two general types corresponding to the methodology used to downregulate gene expression: antisense or double-stranded RNA interference (dsRNAi).
- dsRNAi double-stranded RNA interference
- a full-length or partial gene fragment (typically, a portion ofthe cDNA) can be used in the same vectors described for full-length expression, as part ofthe gene expression cassette.
- the coding region ofthe gene or gene fragment will be in the opposite orientation relative to the promoter; thus, mRNA will be made from the non-coding (antisense) strand inplanta.
- dsRNAi vectors For dsRNAi vectors, a partial gene fragment (typically, 300 to 500 basepairs long) is used in the gene expression cassette, and is expressed in both the sense and antisense orientations, separated by a spacer region (typically, a plant intron, eg. the OsSHl intron 1, or a selectable marker, eg. conferring kanamycin resistance).
- a spacer region typically, a plant intron, eg. the OsSHl intron 1, or a selectable marker, eg. conferring kanamycin resistance.
- Nectors of this type are designed to form a double-stranded mR ⁇ A stem, resulting from the basepairing ofthe two complementary gene fragments inplanta.
- Biolistic or binary vectors designed for overexpression or knockout can vary in a number of different ways, including eg. the selectable markers used in plant and bacteria, the transcriptional terminators used in the gene expression and plant selectable marker cassettes, and the methodologies used for cloning in gene or gene fragments of interest (typically, conventional restriction enzyme-mediated or GatewayTM recombinase-based cloning).
- An important variant is the nature ofthe gene expression cassette promoter driving expression of the gene or gene fragment of interest in most tissues ofthe plants (constitutive, eg. ZmUBIint MOD), in specific plant tissues (eg. maize ADP-gpp for endosperm-specific expression), or in an inducible fashion (eg. GAL4bsBzl for estradiol-inducible expression in lines constitutively expressing the cognate transcriptional activator for this promoter).
- a validated rice cD ⁇ A clone such as the OsPTll cD ⁇ A prepared in Example 14 above, in pCR2.1-TOPO is subcloned using conventional restriction enzyme-based cloning into a vector, downstream ofthe maize ubiquitin promoter and intron, and upstream ofthe Agrobacterium tumefaciens nos 3' end transcriptional terminator.
- the resultant gene expression cassette (promoter, gene ofthe embodiments ofthe invention and terminator) is further subcloned, using conventional restriction enzyme-based cloning, into the pNON2117 binary vector, generating p ⁇ OVCA ⁇ D.
- the p ⁇ OVCA ⁇ D binary vector is designed for transformation and over-expression of the gene ofthe embodiments ofthe invention in monocots. It consists of a binary backbone containing the sequences necessary for selection and growth in Escherichia coli DH-5 ⁇ (Invitrogen) and Agrobacterium tumefaciens LBA4404, including the bacterial spectinomycin antibiotic resistance aadA gene from E. coli transposon Tn7, origins of replication for E. coli (ColEl) and A. tumefaciens (VS1), and the A. tumefaciens virG gene.
- p ⁇ OV2117 contains the T-DNA portion flanked by the right and left border sequences, and including the PositechTM (Syngenta) plant selectable marker and the gene ofthe embodiments ofthe invention gene expression cassette.
- the PositechTM plant selectable marker confers resistance to mannose and in this instance consists ofthe maize ubiquitin promoter driving expression ofthe PMI (phosphomannose isomerase) gene, followed by the cauliflower mosaic virus transcriptional terminator.
- pNONCAND is transformed into a rice cultivar (Kaybonnet) using Agrobacterium-mediated transformation, and mannose- resistant calli are selected and regenerated.
- Agrobacterium is grown on YPC solid plates for 2-3 days prior to experiment initiation. Agrobacterial colonies are suspended in liquid MS media to an OD of 0.2 at ⁇ 600nm. Acetosyringone is added to the agrobacterial suspension to a concentration of 200 ⁇ M and agro is induced for 30min.
- Co-Cultivation is continued for 2 days in the dark at 22°C.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02773582A EP1576163A4 (en) | 2001-09-26 | 2002-09-26 | High-protein-phenotype-associated plant genes |
AU2002337695A AU2002337695A1 (en) | 2001-09-26 | 2002-09-26 | High-protein-phenotype-associated plant genes |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32527701P | 2001-09-26 | 2001-09-26 | |
US60/325,277 | 2001-09-26 | ||
US37052602P | 2002-04-04 | 2002-04-04 | |
US37062002P | 2002-04-04 | 2002-04-04 | |
US60/370,620 | 2002-04-04 | ||
US60/370,526 | 2002-04-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003027249A2 true WO2003027249A2 (en) | 2003-04-03 |
WO2003027249A3 WO2003027249A3 (en) | 2005-07-28 |
Family
ID=27406390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/030475 WO2003027249A2 (en) | 2001-09-26 | 2002-09-26 | High-protein-phenotype-associated plant genes |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1576163A4 (en) |
AU (1) | AU2002337695A1 (en) |
WO (1) | WO2003027249A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1534843A2 (en) * | 2002-08-02 | 2005-06-01 | BASF Plant Science GmbH | Sugar and lipid metabolism regulators in plants iv |
WO2006131477A1 (en) * | 2005-06-06 | 2006-12-14 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
WO2007005980A2 (en) * | 2005-07-06 | 2007-01-11 | Cornell Research Foundation | Dehydrin genes and promoters from coffee |
EP2003205A3 (en) * | 2004-12-28 | 2009-05-13 | Pioneer Hi-Bred International, Inc. | Improved grain quality through altered expression of seed proteins |
CN107201399A (en) * | 2017-05-16 | 2017-09-26 | 浙江海洋大学 | The method for screening the molecular labeling related to few root duckweed root growth |
-
2002
- 2002-09-26 AU AU2002337695A patent/AU2002337695A1/en not_active Abandoned
- 2002-09-26 EP EP02773582A patent/EP1576163A4/en not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030475 patent/WO2003027249A2/en not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
DATABASE GENE BANK [Online] 11 January 1996 CHEN ET AL: 'Oryza sativa globulin-like protein mRNAm clone Ose710, partial cds', XP002987934 Database accession no. U45322 * |
See also references of EP1576163A2 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1534843A2 (en) * | 2002-08-02 | 2005-06-01 | BASF Plant Science GmbH | Sugar and lipid metabolism regulators in plants iv |
EP1534843A4 (en) * | 2002-08-02 | 2007-04-25 | Basf Plant Science Gmbh | Sugar and lipid metabolism regulators in plants iv |
US7858845B2 (en) | 2002-08-02 | 2010-12-28 | Basf Plant Science Gmbh | Sugar and lipid metabolism regulators in plants IV |
US8188339B2 (en) | 2002-08-02 | 2012-05-29 | Basf Plant Science Gmbh | Sugar and lipid metabolism regulators in plants IV |
EP2003205A3 (en) * | 2004-12-28 | 2009-05-13 | Pioneer Hi-Bred International, Inc. | Improved grain quality through altered expression of seed proteins |
WO2006131477A1 (en) * | 2005-06-06 | 2006-12-14 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
WO2007005980A2 (en) * | 2005-07-06 | 2007-01-11 | Cornell Research Foundation | Dehydrin genes and promoters from coffee |
WO2007005980A3 (en) * | 2005-07-06 | 2007-08-16 | Cornell Res Foundation Inc | Dehydrin genes and promoters from coffee |
US8513491B2 (en) | 2005-07-06 | 2013-08-20 | Nestec S.A. | Dehydrin genes and promoters from coffee |
CN107201399A (en) * | 2017-05-16 | 2017-09-26 | 浙江海洋大学 | The method for screening the molecular labeling related to few root duckweed root growth |
Also Published As
Publication number | Publication date |
---|---|
AU2002337695A8 (en) | 2003-04-07 |
AU2002337695A1 (en) | 2003-04-07 |
WO2003027249A3 (en) | 2005-07-28 |
EP1576163A4 (en) | 2006-10-25 |
EP1576163A2 (en) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7777097B2 (en) | Plant disease resistance genes | |
US8115058B2 (en) | Rice promoters for regulation of plant expression | |
CA2413548C (en) | Root-specific promoter from arabidopsis | |
CA2640076C (en) | Genes for enhancing nitrogen utilization efficiency in crop plants | |
US20070016976A1 (en) | Plant genes involved in defense against pathogens | |
US20030135888A1 (en) | Genes that are modulated by posttranscriptional gene silencing | |
WO2003000905A2 (en) | Identification and characterization of plant genes | |
US20150252377A1 (en) | Genes controlling photoperiod sensitivity in maize and sorghum and uses thereof | |
US8426576B2 (en) | Arabidopsis derived promoters for regulation of plant expression | |
WO2003007699A2 (en) | Transcription factors of cereals | |
WO2014164074A1 (en) | Enhanced nitrate uptake and nitrate translocation by over-expressing maize functional low-affinity nitrate transporters in transgenic maize | |
US20120284878A1 (en) | Arabidopsis derived promoters for regulation of plant expression | |
US20050032156A1 (en) | Identification and characterization of phosphate transporter genes | |
WO2018009600A2 (en) | Modulation of rice mpg1 activity to increase biomass accumulation, grain yield, and stress tolerance in plants | |
WO2003000904A2 (en) | Identification and characterization of plant genes | |
US20050235375A1 (en) | Transcription factors of cereals | |
EP1576163A2 (en) | High-protein-phenotype-associated plant genes | |
US20080172765A1 (en) | Plant genes involved in defense against pathogens | |
US7186887B2 (en) | Nucleic acids encoding oryza sativa nuclear cap binding protein 80 and methods of use | |
WO2002081695A2 (en) | Genes that are modulated by posttranscriptional gene silencing | |
AU2005247022B2 (en) | Promoters for regulation of plant gene expression | |
AU2002302504A1 (en) | Oryza sativa nuclear cap binding protein 80 | |
US7763778B2 (en) | Delayed flowering time gene (DLF1) in maize and uses thereof | |
MX2011004216A (en) | NOVEL At1g67330 GENE INVOLVED IN ALTERED NITRATE UPTAKE EFFICIENCY. | |
WO2013152317A2 (en) | Nitrite transporter and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002773582 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2002773582 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002773582 Country of ref document: EP |